{{org_field_logo}}

{{org_field_name}}

Registration Number: {{org_field_registration_no}}

---

Medication Management Policy – Supported Living (Personal Care)

1. Purpose and Scope

Purpose: This policy outlines clear guidelines for safe handling, administration, storage, and disposal of medicines within our Supported Living service. It aims to protect the health, well-being, and dignity of adults we support – including those with mental health needs, and general personal care needs. Key objectives include:

• Safety and Compliance: Prevent medication errors, misuse, or harm by adhering to legal requirements and best practices. The policy ensures compliance with Care Quality Commission (CQC) fundamental standards, the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, NICE guidance, and the Care Act 2014. It reflects current guidance for supported living services registered for Personal Care, where medicines support is provided as an ancillary part of personal care.
• Promoting Independence: Support service users to manage their own medicines whenever appropriate, in line with their wishes and abilities. We encourage self-administration and informed choice to enhance independence and autonomy.
• Clarity in Roles and Processes: Define staff responsibilities in medication management, ensuring accountability at all levels. Provide practical procedures for ordering, receiving, storing, administering and disposing of medicines.
• Person-Centred Care: Align medication support with each individual’s needs and preferences. This includes considering mental capacity, consent, cultural or religious needs, and involving people in decisions about their medicines. Service users’ rights – including the right to refuse medication – are respected at all times.

Scope: This policy applies to all staff of {{org_field_name}} involved in medication support, including:

• Support Staff and Care Workers – those who prompt, assist with, or administer medicines as part of personal care.
• Registered Manager and Team Leaders – responsible for oversight, training, and governance of medication practices.
• Office/Administrative Staff – coordinating prescriptions, medication records, audits, and communication with pharmacies or healthcare providers.

It covers all aspects of medicines management in our supported living settings, from prescribing liaison and receipt of medicines, through to administration, documentation, review, and disposal. The principles apply across the service for all individuals receiving personal care (where medication support is part of their care package).

This policy applies where medicines support forms part of the person’s agreed care and support arrangements within {{org_field_name}}’s Supported Living service. Where there is uncertainty about whether a proposed medicines-related activity falls within the scope of the organisation’s registration, the Registered Manager will obtain appropriate regulatory or professional advice before the service is provided.

{{org_field_name}} is registered with the Care Quality Commission to carry out the regulated activity of {{org_field_regulated_activity}} for {{org_field_service_users_bands}} in supported living settings.

2. Legal and Regulatory Framework

Medication management in this service is underpinned by the following laws, regulations, and guidance:

• Health and Social Care Act 2008 (Regulated Activities) Regulations 2014: Part 3 of these Regulations contains the Fundamental Standards that we must meet. Key standards include:
  • Regulation 12 – Safe Care and Treatment: Requires medicines to be supplied in sufficient quantities, managed safely, and administered appropriately to keep people safe. This means we must have robust systems for the safe ordering, storage, and administration of medications.
  • Regulation 11 – Need for Consent: We must obtain consent for care and treatment. This applies to administering medication – we ensure informed consent is obtained, or if a person lacks capacity, we follow the Mental Capacity Act 2005 for best-interest decisions (see Section 5).
  • Regulation 13 – Safeguarding Service Users from Abuse and Improper Treatment: Protects people from abuse or improper treatment, which includes the misuse of medications. Wilfully withholding medication, giving the wrong medication, or over-medicating to sedate could constitute abuse. We have processes to prevent, identify and respond to any medication-related safeguarding incidents.
  • Regulation 17 – Good Governance: Requires effective governance and auditing of care. We maintain accurate medication records, conduct regular audits, and continually improve our medication management processes.
  • Regulation 18 – Staffing: We ensure staff have the necessary training, competence, and numbers to safely manage medications. Only trained and assessed staff administer medicines, in compliance with this regulation.
  • Regulation 20 – Duty of Candour: If a medication error causes harm, we are open and transparent with the service user (and family as appropriate). We inform them of what happened, provide support and apologies, and notify relevant authorities as required.
• Care Quality Commission (Registration) Regulations 2009: These regulations impose duties on our service as a registered provider. In particular:
  • Regulation 12 – Statement of Purpose: Our Statement of Purpose includes how we manage medications as part of our personal care service. This policy supports that statement by detailing our procedures.
  • Regulation 18 – Notification of Other Incidents: We must notify CQC without delay of certain incidents that affect the health, safety and welfare of service users. In context of medication, any medicine error that results in death, serious injury, or requires police involvement or amounts to abuse must be reported to CQC. (Medication errors not meeting these harm thresholds are recorded and managed internally, but still may require safeguarding notifications locally – see Section 18).
• Care Act 2014: The Care Act underpins the provision of care and support in England. It emphasizes promoting individual wellbeing and meeting assessed needs in a person-centred way. Under the Care Act, supporting a person with managing their medication is recognized as part of meeting their health and care needs. We have a duty to ensure people receive the support they need with medicines as part of their overall care plan, while maintaining their dignity and control. The Care Act also reinforces safeguarding obligations – negligent medication practices can be a form of neglect. This policy aligns with those principles by ensuring medication support is safe, appropriate, and centered on the individual’s needs and choices.
• Mental Capacity Act 2005 (MCA) and MCA Code of Practice: Whenever there are questions about a person’s capacity to understand or consent to their medication, we follow the MCA. The Act’s core principles – assume capacity unless proven otherwise, enable participation in decision-making, act in best interests if capacity is lacking, and use least restrictive options – are embedded throughout our procedures (see Section 5 on Consent and Mental Capacity). Covert administration of medicines or making medication decisions on someone’s behalf must only occur in accordance with the MCA, including proper assessments and best interest decision-making.
• NICE Guidelines – Managing Medicines in the Community: We adhere to evidence-based best practice as described in NICE guideline NG67: Managing medicines for adults receiving social care in the community. CQC expects providers to follow this guidance. Key points from NICE include maintaining accurate medication records, supporting self-management, having clear processes for ‘when required’ (PRN) medicines, covert medication, and staff training. We reference specific recommendations (e.g. the “six rights” of medication administration and robust incident reporting) in relevant sections of this policy.
• Other Relevant Legislation: We comply with the Misuse of Drugs Act 1971 and Misuse of Drugs Regulations 2001 for controlled drugs management. Controlled Drugs (CDs) are subject to special storage, recording, and disposal requirements due to their potential for abuse (see Section 12). We also follow the Data Protection Act 2018 / UK GDPR regarding confidential handling of personal information related to medication (see Section 20 on Confidentiality).

All staff are expected to be familiar with these frameworks. Compliance with legal requirements is not optional – any breach (for example, unsafe management of medicines) could result in regulatory action, including CQC enforcement. By following this policy, staff ensure that we meet or exceed the minimum standards and deliver high-quality, safe support with medicines.

3. Roles and Responsibilities

Safe medication management is a team responsibility that involves care staff, management, healthcare professionals, and the individuals we support. Clear roles and accountability help prevent errors and ensure consistency. The following outlines key responsibilities:

Registered Manager ({{org_field_registered_manager_first_name}} {{org_field_registered_manager_last_name}}):
The Registered Manager holds overall accountability for medication safety in the service. Responsibilities include:

• Oversight and Governance: Ensure that effective systems are in place for ordering, storing, administering, and disposing of medicines in line with this policy and regulatory standards. The manager verifies that the “proper and safe management of medicines” (Regulation 12) is always maintained.
• Policy Implementation: Keep this Medication Management Policy up to date and ensure it is implemented in daily practice. Any CQC feedback or updates in guidance must be reflected in policy revisions. The manager approves all procedural changes and ensures staff are informed of updates.
• Training and Competency: Ensure all care staff receive appropriate medication training and regular competency assessments (see Section 16). The manager schedules training refreshers and maintains records of staff training. No staff should administer medication unsupervised unless assessed as competent.
• Support and Supervision: Provide guidance to staff with any medication-related queries. Conduct spot-checks or supervisions focusing on medication rounds to observe practice. Address any performance issues (e.g. frequent errors or documentation issues) through supervision and retraining.
• Incident Management: Investigate all medication errors, incidents or near-misses. Follow incident reporting procedures (Section 18) including notifications to CQC or safeguarding authorities when required. The manager ensures that learning from incidents is shared with the team to prevent recurrences.
• External Liaison: Coordinate with external healthcare professionals (GPs, pharmacists, community nurses) to ensure people’s medication needs are reviewed and met. The manager works with pharmacies regarding supply issues or compliance aids, and with prescribers for medication reviews or changes.

Care Staff (Support Workers/Care Assistants):
Care staff are on the frontline of administering or assisting with medications. Their responsibilities include:

• Following the Care Plan: Deliver medication support exactly as agreed in the person’s care plan and risk assessment. Care workers only provide the level of medicines support that has been documented and agreed – whether that is administration, assistance or prompting (see Section 4 for levels of support).
• Medication Administration: When administering medication directly, staff must adhere to the standard “rights” of medication – right person, right medicine, right dose, right route, right time, and right to refuse. This includes verifying the identity of the service user, checking the medicine label and MAR chart for correct instructions, and giving the medicine as prescribed. They should remain with the person until the medicine is taken/swallowed and never leave medicines unattended with the person.
• Assistance/Prompting: When assisting (not full administration), follow the care plan instructions such as helping to open containers or reminding the person. Even when prompting or assisting, staff monitor that the person actually takes the medication and note any issues (refusal, difficulty swallowing, etc.).
• Consent and Capacity: Always seek the person’s consent before giving medication. Explain what the medicine is for in an accessible way. If the person declines, do not force them (see Section 9). If you suspect the person doesn’t understand due to impaired capacity, do not proceed without consulting a senior – an MCA assessment and best-interest process may be needed (Sections 5 and 11 address this).
• Documentation: Immediately record all medication given, refused, or prompted on the Medication Administration Record (MAR) or relevant record (see Section 14). Entries must be clear and signed/initialed. Any refusal or omission should be coded appropriately with a note of the reason. Care staff also record general observations in daily notes when relevant (e.g. “Service user complained of pain, PRN paracetamol offered and taken”).
• Monitoring Effects: Be vigilant for any side effects or changes in the person’s condition. If a service user has an adverse reaction, or if medication seems ineffective (e.g. continued pain after PRN analgesic), inform the manager or seek medical advice. Also, observe for non-verbal cues of distress or pain, especially in those with communication difficulties, so PRN medicines can be offered per the care plan.
• Reporting Issues: Immediately report to the Manager/On-call any medication errors or incidents (such as a missed dose, wrong dose taken, or medication discovered dropped on floor). Also report near-misses (e.g. almost giving the wrong tablet but catching it in time) – these are learning opportunities and must be logged. If a prescription or label is unclear, or if medicines are running low, staff must alert the office/manager promptly rather than guessing or risking an error.

External Health Professionals: While not employees of our service, we work closely with external professionals who play vital roles:

• General Practitioners (GPs): Prescribe and review medications. We communicate with GPs to request medication reviews (e.g. if we notice frequent refusals or side effects), to clarify instructions, or to report any concerns (such as ineffective treatment or the need for alternative formulations). GPs should provide clear directions for use, especially for time-sensitive or PRN medicines, and we ensure these directions are followed.
• Pharmacists/Dispensing Chemists: Dispense medications and can advise on safe administration (e.g. whether a tablet can be crushed or if an alternative form is available for those with swallowing difficulties). We consult pharmacists for medication advice, interactions, or proper disposal of medicines. Pharmacists may also assist with compliance aids (though per NICE, monitored dosage systems are only used if assessed as necessary). We involve pharmacists in medication reviews and ask for medication administration record charts if needed.
• Community Nurses or Specialists: For certain individuals, community nurses might administer specific medicines (e.g. injections, insulin, or set up blister packs, feeding tubes). In such cases, we coordinate with those nurses and ensure roles are clear (who gives what and when). We document any medication administered by external professionals in the service user’s records, to maintain a complete picture.
• Family Members/Informal Carers: Some service users have family involved in their care. If family members handle or give any medications (for example during a home visit or outing), we agree on how this will be recorded and ensure they have the information needed. We include details in the care plan if family are assisting with medication at any time.

Service Users: We acknowledge the individuals’ role in managing their own health where possible. Each person has the right to be involved in decisions about their medicines. Those who self-administer (fully or partially) have a responsibility (as appropriate to their abilities) to take medications as prescribed and inform staff of any issues. Our role is to support them, not take over unless necessary for safety. We provide information and encouragement so that service users can be as independent as possible with their medicines.

By clearly delineating these roles and responsibilities, we foster a coordinated approach. Everyone understands their duties and to whom any concerns should be escalated. This clarity helps maintain accountability and ensures that no aspect of medication management “falls through the cracks” – from prescribing to picking up errors, there is always someone accountable at each step.

Assessment of Medicines Support Needs

On admission to the service, before {{org_field_name}} provides medicines support, and whenever a person’s circumstances or medicines change, an individual medicines assessment will be completed.

The assessment will establish:

• the medicines currently prescribed and the purpose of each medicine;
• how the person currently manages their medicines;
• the person’s wishes, preferences and desired level of independence;
• whether the person can self-administer safely;
• whether prompting, physical assistance or full administration is required;
• mental capacity and consent in relation to medicines management;
• communication, sensory or accessibility needs;
• physical difficulties affecting medicines use, including swallowing difficulties or dexterity problems;
• allergies and known adverse drug reactions;
• risks associated with specific medicines, including high-risk medicines and controlled drugs;
• risks of overdose, under-use, misuse, stockpiling or self-harm;
• PRN medicines and how the person communicates or demonstrates need;
• storage arrangements within the person’s home;
• ordering, collection and supply arrangements;
• whether family members or other healthcare professionals are involved;
• any delegated healthcare tasks;
• requirements for sharps, medical devices or specialist equipment; and
• any monitoring required for the medicines prescribed.

The outcome will be recorded within the person’s care plan, medication support plan and risk assessment. The agreed level of support must be clear to all staff.

The assessment will be reviewed following any significant medication change, hospital discharge, change in health or mental capacity, repeated refusal, medication incident, change in living arrangements or evidence that the existing level of support is no longer appropriate.

4. Levels of Support with Medication

Individuals in supported living may require different levels of support with their medicines, depending on their abilities, health needs, and preferences. We tailor our approach for each person, aiming to maximize independence while ensuring safety. The levels of support generally fall into the following categories:

• Self-Administration (Independent): The person manages their own medication entirely. They are responsible for storing their medicines safely, remembering to take doses, and following their prescription. Staff role is minimal – typically just to remind or check if the person has taken their medicines, as agreed in the care plan. We will still have a care plan in place and conduct a risk assessment (see Section 13 on self-medication), but day-to-day control lies with the service user.
• Prompting: Staff remind the person to take their medication at the appropriate times, but do not handle the medication directly. Prompting might include a verbal reminder (“It’s time for your tablets now”) or bringing the medication container to the individual for them to take themselves. Prompting is usually suitable for someone who is forgetful or lacks initiation but is able to take the meds once reminded, and who has capacity to understand the task. Important: Each instance of prompting is noted in daily care notes (to confirm the person took or declined). A MAR chart may not be required for pure prompting support if staff never directly administer, but in our service we often still maintain MAR records to track compliance and any refusals as part of oversight. If a prompted person shows confusion or repeatedly forgets even with reminders, staff should report this – it may indicate the need for a higher level of support or a capacity re-assessment.
• Assisting: Staff physically help the person with certain tasks related to taking medicine, without fully administering it for them. For example, opening blister packs or bottles, reading labels out loud, or handing the pills to the individual if they have difficulty with mobility or coordination. The key distinction is that the person being supported is considered to have capacity and remains in control of actually taking the medicine once it’s handed to them or made ready. Staff are assisting the process but not making decisions for the person. With assistance, a MAR chart is usually kept and staff will record that they assisted with the dose. Any uncertainty from the person (like if they suddenly seem unsure about what to take) means staff should pause and seek guidance – people must have capacity to direct the process if staff are only assisting. If capacity is lacking, assistance/prompting alone is not appropriate; more direct administration with best-interest decision will be required.
• Administration (Full support): Staff take full responsibility for ensuring the medicine is taken correctly. This means the support worker will do everything from checking the prescription/MAR, selecting the correct medication and dose, physically giving the medication to the person (or applying it, in the case of creams/patches, etc.), and confirming it has been taken. Administration is typically required if the person is unable to manage their medicines independently or safely – for example, due to lack of capacity, memory issues, physical inability to handle pills, or high risk associated with the medication. In providing this level of support, staff must follow strict procedures to prevent errors (detailed in Section 8). Administering medication carries the highest responsibility; staff accept accountability to “ensure that the person is given medicine as prescribed”. All administrations are recorded on the MAR, and (where possible) witnessed or double-checked, especially for critical medicines or controlled drugs. We only move to full administration after assessing that lower levels of support are insufficient to keep the person safe. Even then, the person’s consent or best interest (if lacking capacity) is obtained for staff to take on this role.

In practice, an individual’s care plan will specify their assessed level of support for medicines. For example, one person might self-administer their morning medications but need prompting for an evening dose due to memory issues, or need assistance with eyedrops but can do tablets on their own. Staff should always refer to the care plan instructions for each medication and time of day. If a person’s ability changes (for better or worse), we reassess and update the plan accordingly. Our goal is to adjust the support level to the least intrusive that still safeguards the individual – promoting independence in line with the supported living ethos, but intervening fully when required to prevent harm.

Note: Prompting and assisting are only appropriate when a person can ultimately make the decision to take their medication and understand the implications. If a person cannot do so (due to impaired capacity or severe confusion), staff should not merely prompt/assist in a way that leaves the person at risk. In those cases, a switch to full administration under a best-interest agreement (with possible covert methods if needed) would be implemented (see Sections 5 and 11). This ensures we meet our duty to provide safe care (Regulation 12) by not leaving someone without the necessary help to actually receive their treatment.

5. Consent and Mental Capacity

Medication must never be given to someone against their will or without proper consent, unless legal safeguards are followed. We uphold the principles of consent and the Mental Capacity Act (MCA) 2005 at every step involving decision-making about medicines.

Presuming Capacity: We start from the assumption that an adult has the mental capacity to make decisions about their medication, unless there is evidence to the contrary. This means we explain and offer medicines to everyone in our care as a choice they can consent to or refuse. Capacity is decision-specific and may fluctuate – someone might manage simple decisions (like taking paracetamol for a headache) but not more complex ones (like adjusting a heart medication dosage). We assess capacity relative to the specific decision at hand.

Informed Consent: Before administering or assisting with any medication, staff should gain the person’s consent. This involves: explaining what the medication is for, what dose is due, and confirming the person agrees to take it. Explanations should be given in a way the person understands (using plain language, visual aids, or the person’s preferred communication method). For example: “These are your morning tablets for blood pressure – is it okay if I help you with them now?” The person’s agreement might be verbal or implied (e.g. reaching out to take the pills). If a service user questions a medication or is unsure, staff should provide any additional information they can (from the MAR chart or patient leaflet) and encourage them to take it as prescribed, but ultimately the person’s choice is paramount.

If Someone Refuses: An individual with capacity has the right to refuse medication, even if this may adversely affect their health. In cases of refusal, do not force or trick the person into taking the medicine. Coaxing or encouragement can be offered (“Would you like to try in a little while?”), but outright resistance must be respected. The refusal must be documented on the MAR (with the appropriate code) and reported to the manager. We also inform relevant health professionals if the missed medicine could cause harm (for instance, if they refuse critical doses like insulin or anti-seizure medication). If refusals become frequent or put the person at risk, we would involve the GP to review the necessity or possible alternatives, and consider if a capacity assessment is needed for medication adherence. Repeated refusals might indicate the person doesn’t fully understand the consequences (capacity issue) or that side effects are bothering them – either way, a review is warranted.

Assessing Capacity for Medication Decisions: If there is reason to believe a person may lack capacity to understand and make decisions about their medication (for example, advanced dementia, learning disabilities affecting understanding, acute confusion or mental illness episodes), a formal capacity assessment is conducted by a trained staff member or manager, following the MCA guidelines. We assess whether the person can understand the information about the medication, retain it, weigh it, and communicate their decision. This assessment is decision-specific – e.g., “Does Jane have capacity to decide about taking her anticoagulant medication daily?”

• If the person is found to have capacity, we continue to obtain consent and support them in the usual way, even if they occasionally refuse (that is their right). We might explore why they refuse and educate or adjust support, but we cannot override a capacitated person’s decision.
• If the person lacks capacity for the medication decision, we then move to a best interest decision-making process.

Best Interests Decision: Under the MCA, if an adult lacks capacity to consent to a necessary treatment like medication, we must act in their best interests. The manager (or keyworker/ senior staff) will: involve the person’s family, advocate, or legal representative (if available), consult with relevant professionals (GP, pharmacist, community nurse), and hold a discussion or meeting to decide whether giving the medication is in the person’s best interest. All factors are considered – the person’s past and present wishes (maybe they used to be willing to take it), the benefits versus risks of taking or not taking the medicine, and any alternatives. We document the outcome of this best interest discussion clearly in the care plan and MAR chart (for example: “Due to lack of capacity, a best-interest decision was made on 01/10/2025 with Dr. X and daughter present, that staff will administer blood pressure medication daily in Jane’s best interests to prevent stroke risk.”). Best interest decisions for ongoing medication should be reviewed periodically in case the person’s capacity or circumstances change.

Following the MCA Code of Practice: Staff follow the MCA Code of Practice in these scenarios, which provides guidance on involving the person as much as possible and using the least restrictive option. For instance, if a person won’t take a pill because they don’t understand, could it be disguised (covertly, see Section 11) or given in a form they find easier (like liquid) rather than outright restraint? Sometimes waiting until the person is calmer or at a better time of day can help. We try all practical steps to enable consent first.

Documentation: Every time capacity is assessed or a best-interest decision is made regarding medication, staff must document it. This includes noting who was consulted (family, healthcare professionals), and the reasoning behind decisions. This protects both the person and staff by evidencing that we did not make arbitrary decisions.

Importantly, covert administration (hiding medicine in food/drink without the person’s knowledge) is only done when a person lacks capacity and a formal best-interest process authorises it – see Section 11 for detailed safeguards on covert medication. Care workers must never decide on their own to hide medication due to refusal; that would breach trust and legal requirements.

Consent for PRN (“as needed”) medication: Even for medications that are not on a fixed schedule (like painkillers taken only when needed), we seek consent at the time of offering. If the person has capacity, we might ask, “Would you like your pain relief now? You’re due for it if you want it.” If they lack capacity to request it, we base the decision on their best interests and observed need (see Section 10 on PRN for how we determine need), always keeping their welfare in mind.

In summary: We treat adults as autonomous individuals capable of making their own health decisions unless proven otherwise. Medication is no exception – the role of our staff is to support, not to dictate. When capacity is absent, we take on the responsibility to ensure essential treatments are given, but we do so through careful adherence to the Mental Capacity Act. This approach ensures that we uphold both the rights and the safety of the people we support, maintaining compliance with Reg. 11 (consent) and ethical practice.

6. Medication Ordering and Receiving

Timely and accurate ordering of medicines is essential to ensure that service users have a continuous supply of their prescribed treatments. Our service works proactively with GPs and pharmacies to obtain medications on schedule and in a safe manner. The following procedures are followed for ordering and receiving medicines:

Ordering Prescribed Medicines:

• Each service user’s medication needs are recorded in their care plan and a medication list (which may be part of the MAR chart or kept separately). This includes regular prescriptions, the prescribing GP and pharmacy details, and when prescriptions are due for renewal.
• We typically use a 28-day repeat prescription cycle (unless the doctor has specified a different interval). Approximately 1–2 weeks before a person’s current medicines are due to run out, staff will begin the reorder process. For repeat prescriptions, this may involve sending a request to the GP surgery (electronically or via a repeat slip) listing the required items. If the person can request their own repeats, we encourage and remind them to do so, with support as needed.
• The Registered Manager or a designated senior staff oversees ordering to double-check that all necessary medications are requested. This prevents omissions (e.g. forgetting to reorder a less common PRN medication).
• We coordinate with the pharmacy to ensure any adjustments are understood. For instance, if a dose was changed by the GP at a review, we confirm that the new prescription reflects this change. We also inform the pharmacy of any special packaging needs as a reasonable adjustment – for example, large-print labels or easy-open caps for those with visual impairment or reduced dexterity. The Equality Act 2010 requires reasonable adjustments, and pharmacies can often accommodate requests like dispensing tablets in blister packs only if assessed as necessary for adherence. We only use monitored dosage systems (like dosette boxes) if a pharmacist or relevant professional has assessed it’s needed to support the person’s compliance.

Receiving Medications:

• Medications are typically delivered by the pharmacy or collected by a staff member (or family member) depending on arrangements. Deliveries to a person’s home are checked by staff on arrival. We ensure someone is available to receive the delivery – medicines are never left unattended at the doorstep.
• Upon receiving a new medication supply, staff check the following:
  • The labels against the prescription/MAR chart – verifying right person’s name, medication name, strength, and dosing instructions.
  • The quantity received, to ensure it matches what was ordered and what the MAR will be expecting (e.g. 28 tablets for 28 days, etc.).
  • The expiry dates on medicines, especially PRN meds that may last several months. Short-dated items are noted and used first. If any medication is already expired or expiring very soon, we contact the pharmacy to replace it.
  • Any special storage instructions (e.g. “store in refrigerator” or “keep out of light”) are noted so that we store it correctly (see Section 7 on Storage).
• If there are discrepancies or errors (for example, a medication is missing, the wrong strength delivered, or the label is unclear), staff do not administer those medications. We promptly inform the pharmacy to rectify the issue and notify the manager. We document the issue (e.g. in communication logs or incident form if it poses immediate risk).
• Once verified, new medicines are logged (some services use a delivery sheet to sign in medications) and then stored appropriately in the person’s medication storage place. We update the person’s MAR chart to reflect any new items or changes: for example, if a dose changed, we discontinue the old entry and write in the new instructions, with a note “Changed per GP on [date]”. Ideally, the GP’s new prescription or a supporting document is attached to the MAR for reference. Staff should never rely on memory for changes – always update the written records.
• Over-the-Counter (OTC) Medicines: Occasionally a person may want to take non-prescription remedies (like mild painkillers or herbal supplements). We treat these with equal care. The care plan should note if any OTC medicines are agreed for use. We ensure they do not interact with prescriptions (pharmacist or GP advice may be sought). They are ordered/purchased as needed with the person’s consent, and recorded on MAR charts as well (NICE recommends recording all support with OTC medicines too).

Medication Stock Control:

• Staff maintain a basic stock control – being aware of how much medication is on hand and when to reorder. For people on long-term medications, we aim to prevent running out by ordering in advance. If a medication is supplied in blister packs or rolls, we track when the last dose in the current pack will be.
• If a new medication is started mid-cycle (e.g. an antibiotic or a new therapy the GP prescribed outside the usual schedule), we add it to the MAR immediately and ensure the supply is obtained the same day if urgent, or as soon as possible. For antibiotics or urgent meds, a prescription may be collected by staff and taken to the pharmacy without delay. Timeliness is part of safe care – people must have reliable access to prescribed medicines, so we do everything reasonable to avoid missed doses due to supply issues.
• In the event of medication shortages (which can occur if a drug is out of stock nationally), the manager will liaise with the GP and pharmacy for an alternative. We keep the person and their family informed if there’s any anticipated disruption and ensure interim measures (like the GP prescribing a different brand or dosage form) so that treatment continues.

Transportation of Medicines

Where {{org_field_name}} staff are required to collect or transport a person’s medicines, this will only take place as part of an agreed and documented medicines-support arrangement.

Medicines remain the property of the person for whom they have been prescribed and must be transported securely and directly to the intended person or agreed storage location.

When transporting medicines, staff will:

• confirm the identity of the person and the medicines being collected;
• ensure medicines remain in the pharmacy-supplied packaging with dispensing labels intact;
• transport medicines in a secure, discreet container or bag;
• maintain any required storage conditions during transportation;
• take particular precautions with medicines requiring refrigeration;
• keep medicines out of sight and inaccessible to unauthorised persons;
• never leave medicines unattended in an unlocked vehicle or public place;
• transport controlled drugs with additional security appropriate to the assessed risk;
• deliver medicines without unnecessary delay;
• record collection and receipt where required; and
• report immediately any loss, theft, damage, temperature excursion or discrepancy.

Where medication accompanies a person on an outing, holiday, hospital appointment or visit to family, arrangements will be risk assessed and documented. The person will be provided with sufficient correctly labelled medicines for the required period and clear responsibility will be established for administration, storage and recording while away.

Staff must not routinely repackage medicines themselves for journeys or outings. Where separate packaging is required, advice will be obtained from the dispensing pharmacy.

Where refrigerated medicines must be transported, the manufacturer’s and pharmacy’s storage requirements will be followed and an appropriate validated transport method used where necessary.

By rigorously managing the ordering and receipt of medications, we comply with Regulation 12’s requirement to supply medicines in sufficient quantities and prevent gaps in treatment. These procedures also tie into good governance (Reg 17) – accurate ordering records and prompt action on discrepancies are part of our quality assurance. The outcome for our service users is that they receive the right medications on time, without stress or confusion about their supply.

7. Medication Storage and Security

Proper storage of medicines is critical to maintain their effectiveness and to prevent loss or misuse. In a supported living setting, medicines are stored in the person’s own home, not in a central facility – this respects their home environment and autonomy. However, we implement safety measures to ensure medications are kept securely and in the correct conditions.

Individual Storage Arrangements:

• Each service user will have an agreed place in their home for keeping their medication. This could be a designated cabinet, drawer, or container in their room or kitchen – ideally somewhere that is cool, dry, and out of direct sunlight (unless specific storage conditions dictate otherwise). We advise against storing medicines in bathrooms (due to humidity) or near heat sources. The storage spot should be convenient for the person (if they self-administer) yet protected from others if the household is shared.
• For those who require staff administration or where there are safety concerns, a locked medicine storage box or cupboard may be used in the person’s home. The decision to use locked storage is based on risk assessment: for instance, if there’s a risk of other people accessing the medication (maybe the person lives with roommates or has frequent visitors), or if the person is at risk of accidental or intentional overdose. In such cases, the service might provide a small lockable box or ask the landlord to fit a lockable cupboard. The keys to this storage might be held by the service user if they are capable, or by staff (or a combination – e.g. one key with person, a spare with staff). This should be clearly documented in the care plan (who holds keys, how staff access when needed).
• Supported Living vs. Care Home: Unlike a care home, a supported living service does not require a separate clinical medications room, drug trolley, or a medicines fridge locked away from residents. Medications are kept in the person’s own living space and this is acceptable per CQC – a supported living service “does not need a separate medicines fridge or controlled drug cupboard” beyond the person’s own home storage. If certain medicines require refrigeration (e.g. insulin, some antibiotic liquids), they can be kept in the person’s domestic fridge. We typically use a dedicated, clearly labeled container in the fridge to store the individual’s medication to avoid mix-ups with food. Staff will check that the fridge is functioning (in a reasonable temperature range) as part of support.

Security and Access:

• Only authorized personnel and the service user should have access to the medicines. Authorized personnel means the support staff who are assigned to assist that individual, and of course the individual themselves. We do not allow, for example, other residents or unauthorized persons to handle someone’s medication.
• If medicines are kept in a locked box and staff hold the key, staff must ensure the key is kept secure. Often, the key is carried by the shift staff or kept in a secure key safe when not in use (with only staff knowing the code). Keys should not be left lying around.
• Medications must remain in their original packaging with the pharmacy dispensing label intact. We do not transfer pills to pill organizers or different bottles ourselves (except a pharmacist-prepared blister pack). Keeping original packaging ensures we always have the correct instructions and expirations, and reduces error risk. It also helps in identifying each medicine correctly.

Controlled Drugs (CD) Storage:

• Some medications are Controlled Drugs (like morphine, fentanyl, methylphenidate, etc., typically Schedule 2 or certain Schedule 3 drugs). In a person’s own home, there is no absolute legal requirement for them to have a special controlled drugs cabinet unless the person is not in control of their storage. However, given their potential for misuse, we take extra precautions: usually, controlled drugs in supported living will be kept in a locked storage that only staff and the individual (if appropriate) can access. For example, if a person self-administers their morphine, they might keep it in a locked cash box that they have a key for, to prevent any visitors from accessing it. If staff administer it, we keep it locked and may hold the key during visits. We do record controlled drugs administration in a dedicated register or log (see Section 12).
• Importantly, even if not as strict as care homes, the storage must be secure. We treat any strong opioid or sedative with the same care – away from others, under lock and key if any doubt about security. This aligns with our safeguarding duty to prevent misuse or theft.

Environmental Conditions:

• Room temperature medications are kept typically at room temp (below 25°C). We ensure the storage location is not prone to overheating (for instance, not in direct sun by a window, or not next to the stove). If during summer a particular room gets very hot, we might advise moving medicines temporarily to a cooler spot or ensure air circulation.
• Refrigerated medications: As mentioned, go in the fridge. Staff should discreetly verify that the fridge is working; extreme fridge temperatures (too warm or if it’s freezing things) can spoil meds. The acceptable range is usually 2-8°C for most fridge items. We can use a fridge thermometer if needed for critical meds like insulin.
• Controlled drug cupboard (if used): In rare cases where a person has a large quantity of CDs or multiple people’s CDs are stored (e.g. a shared house with a lockable cabinet for each), we ensure any storage furniture meets basic standards – e.g. a locked metal box secured in place for Schedule 2 drugs. But again, CQC notes supported living doesn’t require the typical care home CD cupboard, so we balance security with being in someone’s home.

Medical Gases and Oxygen

Where a person uses prescribed medical oxygen or another medical gas, {{org_field_name}} will only provide support within the person’s assessed care plan and the instructions of the relevant healthcare professional and supplier.

Staff will not alter prescribed oxygen flow rates or treatment settings unless specifically authorised, trained and competent to do so.

Where oxygen is used:

• the prescribed flow rate and method of delivery will be clearly documented;
• staff will understand when and how oxygen should be used;
• oxygen cylinders and equipment will be stored securely, upright or otherwise secured as instructed by the supplier;
• oxygen will be kept away from flames, smoking materials, heat sources, oils, grease and other ignition risks;
• appropriate “No Smoking/Oxygen in Use” precautions will be followed where required;
• cylinders and equipment will be checked for damage and handled according to supplier instructions;
• staff will know what to do in the event of equipment failure or an emergency;
• sufficient supplies will be maintained where this falls within the person’s agreed care arrangements; and
• any concerns about oxygen therapy will be referred immediately to the appropriate healthcare professional or oxygen supplier.

Staff supporting a person with medical oxygen must receive appropriate information, training and competency assessment relevant to the support they provide.

Access by Service Users:

• If a person is self-medicating, they have full access to their medicines. We still encourage them to store securely (especially to keep out of reach of any children visiting, or to avoid accidental taking). If someone has cognitive impairments but insists on keeping their meds accessible, we do a risk assessment. For example, if there’s a risk they might take extra doses, we may negotiate to hold the medication or use a timed dispenser device. Any agreement to limit the person’s direct access (like staff holding keys for a box) should ideally be with consent, or if they lack capacity, done in best interest (the least restrictive option to keep them safe). We document this clearly.
• In some cases, a person with mental health needs might be at risk of self-harm or overdose. In such situations, very close control of medications is needed (possibly only giving small supplies at a time). This is handled sensitively and usually with multi-professional input (GP, psychiatrist) – it might involve daily dispensing rather than giving a whole 28-day supply to the person. We handle these on a case-by-case basis, always aiming to protect the individual from harm while respecting their rights as much as possible.

Storage of Medicines for Multiple People:

• In supported living, each person’s medicines are stored separately in their home. We do not store different individuals’ medications together. In a setting where staff office is on-site, we might have a storage for documents like spare MAR charts or maybe a spare key for a medicine box, but we do not stock people’s medication centrally (aside from perhaps a small emergency stock like homely remedies if agreed by GP – but normally not in domiciliary settings). This avoids any mix-ups and maintains each person’s control over their own medicines.

Regular Checks:

• Staff periodically check the storage conditions and contents. For example, during medication administration visits, a staff member may note if any medications are running low, if any are nearing expiration, or if any are improperly stored. We remove and properly dispose of any medication that has expired or is no longer needed (see Section 19 on Disposal).
• We also ensure that medication storage areas are kept tidy and organized. Especially if a person has many medications, keeping them in a labeled box or compartment can help both the person and staff manage them. However, we avoid mixing different medicines in one bottle or any unlabeled containers. Everything should correspond to a pharmacy label and MAR entry.

By following these storage guidelines, we meet the requirements of keeping medicines safe and secure as part of providing safe care (Regulation 12). We also respect that the service user’s home is their private space – thus, we find solutions that integrate safety into their home in the least intrusive way. Storing medicines correctly also preserves their quality (preventing deterioration) and ensures they will have the desired effect when administered. Staff are trained to treat medication storage seriously: a well-locked cupboard and a well-organized medicine box can be as lifesaving as the medicine itself, because it prevents errors and misuse.

The storage arrangements will be agreed with the person, or established through an appropriate Mental Capacity Act best-interest decision where the person lacks capacity, and recorded in their care plan

8. Administration Procedures

When staff take on the responsibility of administering medication (as opposed to just prompting or assisting), it is critical that a strict procedure is followed every single time. Adhering to a consistent administration process helps prevent mistakes and ensures each person receives their medication safely and correctly, as prescribed. The following step-by-step procedure must be used by staff for each medication administration:

Preparation:

1. Wash or sanitize hands thoroughly before handling any medicines or touching a person’s mouth/appliance. This prevents infection and contamination. If the medication is to be given by a route that requires gloves (e.g. applying creams, eye drops), put on disposable gloves after hand hygiene.
2. Gather the equipment needed – the person’s MAR chart, pen, any measuring devices (for liquids a measuring cup or oral syringe, for topical a spoon or applicator), and the medications themselves from the storage location. Ensure you have adequate lighting to read labels and MAR entries.
3. Check Identity: Confirm the identity of the service user. In supported living, staff usually know the individual well, but it remains good practice to double-check, especially if multiple people are present. For example, call the person by name or check any photo ID on file if needed. This aligns with the first “Right” – right person.

The Five (or Six) Rights Check: Before giving any medicine, staff must verify the core details (preferably by cross-referencing the pharmacy label on the medication packaging and the MAR chart):

• Right Person: Confirm the medication is intended for this specific service user. (Never give medications labeled for someone else, even if you think it’s the same drug – names must match exactly).
• Right Medicine: Check the name of the drug on the label and MAR. Many drug names look or sound alike, so read carefully. If the MAR says “Metformin 500mg” ensure the tablet packet also says “Metformin 500mg”.
• Right Dose: Check the strength of the medicine and the dose to administer now. E.g., label might say “Take 2 tablets (500mg each) in the morning” – ensure you have the correct number of tablets or measure the correct volume for liquids. If the MAR/directions allow a variable dose (e.g. “one or two tablets”), decide the appropriate dose based on the care plan or PRN protocol (if unclear, do not guess – consult a senior or the prescriber).
• Right Route: Verify how the medication is to be given: by mouth (swallowed), sublingual (dissolved under tongue), topical (applied on skin), eye/ear drops, inhaled, etc. Make sure you administer via the correct route. For instance, a tablet meant to be dissolved in water (effervescent) should not be given whole. If an inhaler is prescribed, ensure the person uses the correct technique – assist if needed with a spacer device.
• Right Time: Check that it is the correct time for the dose. MAR charts usually have administration times. There is often an accepted window (e.g. 30-60 minutes either side of prescribed time) but try to be as punctual as possible, especially for time-critical medications (like Parkinson’s disease meds, insulin, antibiotics where timing matters for blood levels). Also confirm that the appropriate interval has passed since the last dose (important for PRN or when doses are close together). If the person is about to eat or just ate and the med has relation to food (e.g. “before meals” or “with food”), ensure timing aligns with those instructions.
• Right to Decline: Always remember the person’s right to refuse (the unofficial sixth “R”). You are about to give the medication, but pause and confirm one more time that the person is consenting. “Here is your [name of med]. Okay to take it now?” This gives the person an opportunity to agree or express any hesitation. If they hesitate or say no, then follow refusal protocol (Section 9) rather than pushing ahead.

Administration:
4. Explain and Engage: Let the person know what you are giving them, especially if they have multiple medications. For example, “These two are your blood pressure pills and here is your aspirin.” This continues the informed consent process and can help the person feel involved. Some service users like to take their medications themselves once handed to them – that’s fine if safe. Others prefer staff to place it in their hand or even mouth – do whatever the care plan indicates and the person is comfortable with.
5. One person at a time: Administer medication to one service user at a time – complete the process fully before moving to another task or person. This prevents mix-ups. In supported living, typically you’re dealing with one person’s meds at a time anyway, but if in a shared environment, never prepare meds for two people simultaneously.
6. One medication at a time: Especially when transcribing to MAR or checking, handle each drug one by one. If giving several medicines, it can help to prepare them in a small clean container or lid rather than holding many packets at once – but ensure you keep them identifiable. For oral solid meds, pop the required tablets out of blister packs just prior to giving (this maintains stability). Do not remove tablets from packaging hours in advance. For liquids, shake if required (per label) and measure accurately at eye level. For topical, check the site of application is correct (e.g. which eye or which part of body).
7. Assist the person in taking it: Provide water or the appropriate beverage (avoid contraindicated ones – for example, no grapefruit juice if interacting, or not with milk if it affects absorption, but these cases are rare and usually labeled). Ensure the person actually swallows the pills. Some individuals may pocket tablets or spit them out later due to difficulty swallowing or dislike. Observe and kindly check: “Let me see, have you swallowed it all?” especially if you’re unsure. For patches or creams, ensure they adhere and cover them if needed (and remove any old patch first if applicable!). For inhalers, ensure the person inhales at the same time as pressing the canister, or assist as per training.
8. Stay until completion: Do not leave a person’s medication on the table for them to take “later”. This is a common source of errors – the dose could be forgotten, knocked over, or taken by someone else accidentally. The staff member should remain with the service user until they have taken the medicine. The only exception might be if the care plan explicitly allows a self-take scenario (like leaving night medication by bedside at request, and even then, this should be risk-assessed). Generally, for any administered dose, witness it being taken.

Post-Administration (Documentation and Follow-up):
9. Immediate Recording: Right after giving the medicine (not before, and not hours later), document the administration on the MAR chart. Use a clear, non-erasable pen (usually blue or black ink). Initial or sign in the correct date/time slot for each medication given. If the MAR is electronic, enter the data accordingly. This real-time documentation is crucial – it prevents double dosing by someone later and provides an accurate record. Never sign for a medicine you have not personally given. If you prepared it but the person refused or vomited it, you must not sign it as given; instead use the appropriate code or note (see Section 9 for how to record refusals or doses not given).
10. Double-Check (if required): For certain medications, a second staff check is required by policy or care plan (for instance, controlled drugs administration might require two staff signatures, or insulin doses might be double-checked). In supported living, having two staff present isn’t always feasible, but if it is for a particular case, follow that protocol. If alone, triple-check yourself on those high-risk meds and maybe call a senior if any doubt at all.
11. Monitor for Immediate Effects: After administration, especially of PRN medication given for symptoms, monitor the person for a short while. For example, if you gave a PRN inhaler for asthma, check if their breathing improves. If you gave pain medication, note if their pain seems to ease in the expected timeframe. If any adverse reaction signs appear (allergic symptoms like rash, swelling, difficulty breathing, or even unexpected side effects like extreme drowsiness), be prepared to take appropriate action (contact GP or emergency services depending on severity).
12. Secure Medications Again: Return any medication containers back to the person’s storage promptly and securely. Don’t leave medication boxes out in the open after giving the dose. Lock the storage if required. This keeps the environment safe and tidy.
13. Prepare for Next Time: If any dose was the last in the pack or a new order is needed soon, make a note (for example, circle on MAR or inform the team) so that reordering happens in time (link to Section 6 ordering).

Special situations during administration:

• If the person is absent during a scheduled medication time (e.g. out with family or at a day activity), the care plan should outline what to do. We might send the medication with them (if risk-assessed and allowed) or arrange for them to take it before/after the outing. We document any such deviations. Never give an extra dose in advance “just in case”; each dose should be taken at its proper time under supervision or by the person if self-medicating. If they miss it due to being out, see Section 9 on missed doses.
• If the person is asleep at medication time and it’s not critical to wake them (determined by GP guidance – some meds should be given even if sleeping, others can wait), we might delay the dose within a safe window. For example, if someone goes to bed early and a 10pm dose is due, we might give it slightly earlier if agreed, or wake them if it’s essential (like Parkinson’s meds often need exact timing). Always follow the individual plan or consult medical advice for such adjustments.
• If vomiting or illness occurs after taking medicine (e.g., they vomit shortly after), note the time and contents if possible, and seek advice whether to re-dose. Generally, do not repeat a dose unless a healthcare professional confirms it (due to risk of double dosing if some was absorbed). Make the person comfortable, monitor, and report the event.

Throughout the administration process, maintain a calm, focused demeanor. Do not allow interruptions – if the phone rings or another service user asks for help mid-round, where possible finish what you’re doing safely or pause without losing your place (e.g., keep the medication secure and return to complete documentation). Medication administration requires full attention. By following this disciplined approach, staff uphold the standards of safe care and treatment as required by Regulation 12 and professional guidelines. This systematic process, along with vigilance and person-centered communication, greatly reduces the chance of errors and ensures service users get the maximum benefit from their medications.

9. Missed or Refused Doses

Despite our best efforts, situations can arise where a medication dose is missed or a person refuses to take it. It’s vital that such instances are handled correctly to protect the person’s health and maintain proper records. This section details what staff should do in these events:

Refused Doses:
If a service user refuses to take a medication:

• Do not force or coerce. The individual has the right to decline a medication if they have capacity to make that decision. Never hide the medicine in food on the spot (covertly) or attempt to physically force it into them – these actions are not permitted and can be considered abuse. Instead, remain calm and respectful.
• Encourage and Explain (Once): Gently ask why they don’t want to take it, and provide any reassurance or information that might address their concerns. For example, “I understand you don’t like how this pill tastes. It’s important for your blood pressure. Perhaps we can ask the doctor if there’s an alternative, but it’s best not to miss it. Would you like to try with some yogurt to help swallow it?” Do not badger or nag; a gentle encouragement is enough.
• Respect the First No: If they firmly refuse after explanation, accept that answer. Pushing repeatedly can distress the person and damage trust. Some people might take it if offered a bit later when in a different mood – use your judgment per the care plan (e.g., “okay, we’ll leave it for now and try in half an hour”), but constant re-offering in the same session can feel like pressure.
• Record the Refusal: On the MAR chart, mark the dose as refused using the designated code (often “R” for Refused) and circle it or follow whatever notation policy we have. Write a brief note if required (some MARs have a back side or notes section) like “Refused after two attempts – will inform GP if continues.”
• Inform the Manager/On-call: Let a senior know about the refusal, especially if it’s a critical medication (e.g., insulin, anticoagulant, anti-seizure medication). The manager can advise on whether to contact a healthcare professional immediately for advice. For instance, missing a dose of warfarin or insulin may need same-day guidance.
• Notify Healthcare if Needed: If a dose is essential or multiple refusals occur, call the GP or NHS 111 for advice. They might say to monitor till next dose, or they might want to arrange a check (like INR test if warfarin missed, etc.). Document any advice given.
• Persistent Refusals: If the person has refused more than once, schedule a medication review with their GP. Perhaps the medication can be changed to a form they prefer (liquid instead of pill, once-daily instead of multiple times, etc.), or maybe it’s causing side effects that make them unwilling. Also consider a capacity assessment if they truly don’t understand the importance and it’s harming their health – they might lack capacity for that decision, in which case best-interest strategies (possibly covert administration) might be considered (Section 11). Involve family if appropriate – sometimes a familiar voice encouraging can help, but only if the person is comfortable with that.
• High-Risk Medications: For certain medications (like psychiatric meds in someone with mental health needs), refusal might lead to relapse or significant risk. The care plan for those individuals should have a contingency (e.g., if they refuse antipsychotic twice, contact mental health team). Always follow individual protocols for high-risk situations.

Missed Doses (Error or Other):
A missed dose can occur for reasons other than refusal – for example, a dose was forgotten by staff (administration error), the person was unavailable (out of the house or asleep), or vomiting prevented administration.

• If a Staff Error (Forgotten): As soon as a missed medication is realized, ensure the person’s safety first. Determine how late the dose is and the medication type. If it’s within a short window (say, realized 30 minutes later), it may be appropriate to still give it – but check guidance or pharmacy advice especially if it’s a drug where timing is strict. If it’s long past or nearly time for next dose, do not double dose. For example, if a morning pill was missed and it’s now afternoon, generally you skip it and continue as normal unless a GP advises otherwise.
  • Inform the manager immediately of the error.
  • Contact a healthcare professional for advice if the medication is critical (e.g., missed insulin – blood sugar might rise, so maybe they need an adjusted dose; missed Parkinson’s med – risk of symptom flare, etc.).
  • Monitor the person for any effects of missing the dose (do they develop pain because analgesic missed? Any withdrawal or symptoms re-emerging?).
  • Document the missed dose on the MAR with the appropriate code (often “O” or “X” for omission) and write a note “dose omitted in error, notified GP” or similar. Also complete an incident report as per Section 18 since this is a medication error.
  • Be honest with the person – duty of candour applies. Apologize and explain if appropriate: “I’m sorry, I realized I missed giving you your 8AM dose of medication. We have spoken to the doctor and will follow their advice. Let’s check how you’re feeling.” Many times, one missed dose may not cause immediate harm, but transparency is key.
• If the Person was Out/Unavailable: If a dose could not be given at the usual time because the person was not present or was unable (e.g. at a hospital appointment or fell asleep early), handle as follows:
  • Check the care plan – sometimes it will say “if dose missed, can be given within X hours”. If still within that safe window upon their return/waking, administer the dose late and mark it as given (noting the actual time).
  • If they completely missed it (e.g., out all day and missed lunchtime dose), mark as missed on MAR and usually do not double up or change timing without advice.
  • If family or another caregiver gave the dose while out, make sure to record that. Ideally, arrangements for others to give meds while out should be agreed beforehand and we should verify with them afterward what was taken.
  • Inform the manager if the missed dose could have health implications. Possibly call GP to check (for instance, missing an antibiotic dose – they might say just continue schedule; missing a dose of epilepsy meds – they might advise taking it as soon as remembered, etc.).
  • Incorporate plans to prevent future misses: maybe if someone often goes out at dose time, adjust the schedule with GP’s approval (some meds can be taken slightly earlier or later to accommodate lifestyle).
• If the Person Vomits or Spits Out: If they vomit shortly after taking medication or spit it out:
  • Treat it as if the dose may not have been fully taken. Do not re-administer without clinical advice, because some portion might have been absorbed. Document on MAR (e.g. “may have vomited dose”) and inform GP especially if it’s important (they may advise to give another dose or to skip till next).
  • If spit out and you retrieve the whole pill intact, you know it wasn’t ingested – you could attempt once more if the person agrees (and it’s not compromised by stomach content). But often it’s best to seek advice.
  • Observe the person for any immediate needs (if it’s a med for seizures or diabetes, for example, be more vigilant as the effect might not occur).

Documentation and Communication:
Every missed or refused dose must be clearly documented on the MAR with the appropriate code and explanation. Additionally, it should be recorded in the daily notes or an incident form if it’s significant, so there is a clear narrative of what happened and what was done about it. This ensures continuity of care – other staff coming on shift know that “Dose X was missed/refused and here’s what’s been done.”

We also update the care plan if needed. For example, after multiple refusals, the care plan might be updated: “X frequently refuses her 8pm dose; GP has been consulted and we will offer at 9pm before bedtime which she seems to prefer.”

Follow-Up:

• After a refusal or missed dose, continue to watch the service user’s condition. If they refused a painkiller, are they now in pain an hour later? If they missed a blood pressure pill, is their BP elevated or do they feel unwell? Report any arising issues.
• Use such incidents as learning opportunities – in staff meetings or handovers, discuss what could prevent missed doses (e.g., better shift handover, alarms for time-critical meds, etc.) and strategies to encourage those who refuse (like involving them more, checking if the medication can be given at a different time when they’re more receptive, or if formulation can change).

By handling missed and refused doses in this structured way, we ensure compliance with regulations (Reg 12 Safe Care – acting appropriately on missed treatments to avoid harm, and Reg 17 Good Governance – proper recording and remedial action). We also maintain the trust of service users by respecting their choices and being open about mistakes. Remember: one missed dose is usually fixable; what’s critical is our response – prompt, transparent, and focused on the individual’s well-being.

10. PRN (As-Needed) Medicines

“PRN” medications (from the Latin pro re nata) are those given only when needed, rather than on a fixed schedule. They might be used for symptoms that occur intermittently, such as pain, anxiety, insomnia, or seizures. In our supported living service, PRN medicines are handled with particular care to ensure they are used effectively and safely.

Examples of PRN medications we may manage include analgesics (e.g. paracetamol for occasional pain or headaches), laxatives taken only when required for constipation, inhalers for asthma relief, or anti-anxiety tablets used during acute stress. Some individuals with mental health needs might have PRN medications for agitation or panic attacks, while others with physical conditions might have them for symptom flare-ups.

Individual PRN Protocol (Care Plan):
For each PRN medicine a person is prescribed, we maintain a person-centred PRN protocol as part of their care plan or a dedicated PRN support plan. This protocol provides staff with clear guidance on when and how to offer or administer the medication. It includes:

• Purpose of the Medication: What condition or symptom is the PRN intended to treat? For example, “Paracetamol 500mg – for relief of mild to moderate pain or fever.” Having this clearly stated helps staff recognize when it’s appropriate to consider giving it.
• Signs and Symptoms Indicating Need: Specific indicators staff should look for. For instance, if the person can verbalize, they might ask for the medicine (“I have a headache, can I have my painkiller?”). If the person cannot communicate verbally or has dementia, the plan should list observable cues (facial expressions of pain, moaning, holding a part of body, change in behavior like agitation could indicate pain). For anxiety PRN, cues might be pacing, shaking, or the person doing something that signals distress. We also note whether the individual is able to request it or needs prompting/observation by staff to identify the need.
• Dosage and Frequency Instructions: The protocol reiterates the prescribed dose (e.g. “take 1 tablet” or “may take 1 or 2 tablets” – if a variable dose is allowed, the plan should clarify how to decide which, like start with one and if pain not relieved in 1 hour, can take second) and the minimum interval between doses (e.g. “every 4 hours as needed”) and the maximum in 24 hours. For example, “Diazepam 2mg tablets PRN for acute anxiety, take one when needed, max 2 tablets (4mg) in 24 hours.” This prevents accidental overdose or too-frequent dosing by ensuring staff know the limits. If a variable dose is prescribed, the prescriber’s guidance is followed – staff should not make arbitrary decisions on dose without clear criteria.
• Alternatives and Non-Pharmacological Interventions: Often, especially for things like anxiety or mild pain, the care plan will suggest trying other measures before resorting to medication. For example, for pain: “Ask if the person would like to rest, use heat pad on site of pain, or have a distraction activity first.” For anxiety: “Use calming techniques from support plan (deep breathing, quiet environment, reassurance) and offer PRN medication if the anxiety does not ease within 15 minutes.” Including such alternatives ensures we don’t automatically give medicine without considering other support. It’s also part of person-centred care to avoid over-reliance on drugs when other support might help.
• Specific Instructions: If multiple PRNs are available for the same symptom, the plan should guide which to use first. For example, if someone has both paracetamol and ibuprofen PRN for pain, the plan might state “Use paracetamol first for headaches; if pain not relieved in 2 hours, you may offer ibuprofen later if appropriate.” Or “If two different inhalers are PRN (like salbutamol vs ipratropium for COPD), clarify the sequence or criteria.”.
• Outcome Monitoring and When to Seek Help: The plan should state how soon and what to check after giving PRN. E.g. “Check pain level after 1 hour. If no relief after maximum PRN given, contact GP.” Or “If PRN lorazepam (an anxiety med) is used, monitor sedation level for next 2 hours, ensure safety from falls.” Also, if the symptom requiring PRN persists or worsens despite medication, staff should know to inform a doctor (for example, repeated angina requiring GTN spray might mean calling GP or 999 if severe).
• Review and Duration: PRN usage should be reviewed periodically. The care plan might note: “If using paracetamol PRN more than 3 times a week, inform the GP – the regular regimen may need adjustment or underlying issue reviewed.” Or “This PRN is intended for short-term use only (e.g., 1 week post-surgery); if still needed beyond that, contact prescriber.”. Also, at each formal care review or healthcare review, PRNs are assessed to see if still required or if any changes needed.

Offering and Administering PRN:

• Timing and Visits: In home care/supported living, staff might not be present 24/7. The PRN plan should consider times when staff are not there. For example, “For insomnia med: staff support is only evenings; if person wakes at night needing it, they self-administer from a pre-dispensed dose on bedside per risk assessment” or family assists. Or, “If person needs PRN outside of care visit times, they have been provided an easy-open bottle to self-take, and will inform staff next visit.” We communicate with family or other supporters so they know when to call us or a professional. Care plans can specify communication routines (e.g., family will call agency if they had to give PRN at weekend). addresses homecare scenarios: ensuring PRN can be managed outside regular visit times by planning with family or others.
• During a Visit: If staff identify or the person requests a PRN during a support visit, follow the protocol. Confirm the last time it was taken (check MAR for that day or ask the person to avoid overdose). Determine if criteria are met (e.g. pain of at least moderate level, or specific sign present). Then administer as you would a regular med, but ensuring to record additional details (see Recording below). Always make sure the person actually needs it – PRN isn’t “just in case”; it’s for a present need.
• Effectiveness and Follow-up: After giving a PRN, we make a point to observe the person and ask if it helped when enough time has passed (usually documented in plan, e.g. 30 min for inhaler, 1 hour for pain tablet). This is important for evaluating whether the PRN is doing its job or if further action is needed (like contacting a doctor if no relief).

Recording PRN Use:
Every administration of a PRN medication must be carefully documented on the MAR and include certain details:

• Clearly note the exact time it was given (especially important because PRNs might not align with standard med rounds and we need to count intervals).
• Document the reason for giving it – e.g., “complained of headache (pain 6/10)” or “signs of anxiety observed (shaking, tearful)”. Some MAR charts have a separate section for PRN reasons or we might use the daily notes if space is an issue.
• If a variable dose was prescribed (like 1-2 tablets), record how much was actually given: “given 2 tablets = 1g” or “given one spray GTN”.
• Later (within a few hours), record the outcome/effectiveness: e.g., “Outcome: after 1 hour, headache improved; pain 2/10, person reports feeling better” or “Outcome: no effect, contacted GP.” This might go in daily notes or on back of MAR depending on documentation system. It is important because it helps healthcare professionals to review whether the PRN is useful or needs changing, and for staff to know if repeating dose is appropriate.
• Keep track of remaining stock perhaps more vigilantly with PRNs since they aren’t given routinely – make sure there’s enough on hand and that expiry dates are checked (some PRN like nitroglycerin spray or insulin pens have limited stability after opening, note those).

Reviewing PRN Usage:
We analyze PRN usage patterns. If a PRN meant for occasional use is being used very frequently, this could indicate the person’s condition has changed or is not well-controlled by their regular meds. For example, if someone is using a PRN inhaler daily, the asthma might need a better maintenance plan; or taking PRN painkillers every night might mean the regular pain management is insufficient. In such cases, staff will alert the GP or nurse to review the treatment plan. Conversely, if a PRN is never used for months, the GP might decide to discontinue it at the next review (no point keeping unnecessary meds around).

Special Considerations for Psychotropic PRNs (Challenging Behaviour/Mental Health):

• If PRN medicines are prescribed for managing distress or agitation (like a sedative or antipsychotic to be used only if someone becomes very agitated), staff need to be extra cautious. The care plan should emphasize using non-medication strategies first to de-escalate situations. Medication should be a last resort, for the minimum necessary period.
• We follow NHS initiatives like STOMP (Stopping Over-Medication of People with a learning disability or autism) if relevant, ensuring that such PRNs are reviewed by prescribers regularly and not overused. Overuse or inappropriate use of sedating PRNs to “control” someone can be considered a form of chemical restraint and even abuse if done without proper justification.
• If PRN is used to manage behaviour, we document the circumstances and inform relevant professionals (and possibly care commissioners). Frequent need might trigger a review of the person’s behaviour support plan or environment. Any overuse or patterns that suggest PRN is being relied on instead of positive support will be addressed immediately – possibly via a safeguarding process if it appears the medication is being used inappropriately as a restraint.

Safeguarding Aspect:

• Medications used PRN that have dependency risks (like benzodiazepines) or where misuse is possible are locked and monitored. If there’s any concern the person might request them more often than needed or someone else could be using them, that’s taken seriously.
• We ensure PRN meds, just like regular meds, are only used for the person intended and for the right reasons. E.g., we wouldn’t use another person’s PRN med for someone else, even if symptoms appear similar – each medication is specific to each individual’s prescription.

Communication:

• Staff will communicate with each other at handovers about PRNs given: “I gave John one PRN paracetamol at 3pm for a headache, he felt better by 4pm.” This prevents confusion or unintentional repeat dosing by the next staff.
• We also inform the person (if they have capacity) of their PRN usage pattern: for instance, “You’ve taken your anxiety medicine a few times this week, shall we discuss with your doctor if everything’s alright or if we need a change?” – involving them in the conversation about their symptoms and meds.
• Family or advocates might also be updated, with the person’s consent, especially if PRN usage has health implications (like frequent use of laxatives).

In summary, PRN medications require judicious use: the right medicine at the right time for the right reason. By having thorough PRN protocols and careful documentation, we ensure PRNs truly benefit the service user and do not become a loophole for error or over-medication. This approach is in line with CQC expectations that adult social care providers have clear policies for PRN medicines and that staff know exactly how and when to administer them safely and effectively.

11. Covert Administration of Medication

Covert administration refers to giving a person medicine without their knowledge or consent, typically by disguising it in food or drink. This is a serious intervention that infringes on a person’s autonomy, and it is only ever used as a last resort when it is in the person’s best interests to receive essential medication and they lack the mental capacity to consent or refuse. Our policy on covert medication strictly follows legal and ethical guidelines, particularly the Mental Capacity Act 2005 and associated best practice.

When Covert Administration May Be Considered:

• The individual must be assessed as lacking capacity to make informed decisions about the specific medication. If a person is habitually refusing medication but has capacity to do so, we cannot give it covertly – we must respect their refusal or seek alternative solutions through persuasion or treatment changes. Covertly hiding medicine in food for someone who has capacity is a violation of their rights and is considered abuse.
• The medication in question should be essential for the person’s health and wellbeing, such that not receiving it is likely to lead to serious harm. Examples might include refusal of crucial anti-psychotic medication by someone who then becomes a danger to themselves, or refusal of antibiotics for a serious infection in a person with dementia who doesn’t understand the need. If the medication is not life-sustaining or critical, covert methods are hard to justify – perhaps the treatment could be altered or even discontinued.
• All other options have been tried or considered: e.g., offering the medicine in different forms (crushing tablets is generally not allowed without prescriber approval, but maybe the doctor can prescribe a liquid or patch instead that the person might accept), offering at different times or by different staff (maybe the person refuses with one carer but takes it from another they trust), explaining consequences in simpler terms, etc. Only when these measures fail to ensure the person gets the necessary medicine do we move to covert.

Authorisation Process:
If covert administration is deemed potentially necessary, the following best-interest decision process must take place:

1. Capacity Assessment: A formal documentation that the person cannot understand, retain, or weigh the decision about taking the medication and thus lacks capacity regarding that medication. This might be done by the manager or a qualified professional, and should be recorded (date, who did it, outcome).
2. Best Interest Meeting: We convene a meeting (or at least a discussion) involving relevant parties – this typically includes: the GP or prescribing doctor, a pharmacist, care staff who know the person well (like keyworker or manager), and the person’s family or advocate (especially any holder of a Lasting Power of Attorney for health/welfare, they must be involved as they have legal authority). In this meeting, we discuss the risks and benefits of covert medication. Key points:
   • Is giving the medicine covertly better for the person than not giving it at all? (Usually yes if it’s essential, but consider quality of life too – sometimes forcing medication might cause distress that outweighs benefits if the benefit is marginal.)
   • Could the medication be given in a less restrictive way? (For example, if it’s a bitter pill, could it be mixed with jam openly telling them “here’s some jam with medicine” rather than fully hiding? Or could an injection by a nurse be an option if they won’t take orally?)
   • Input from the pharmacist is crucial: some medicines should never be crushed or mixed with certain foods because it can alter their effect or cause harm. The pharmacist will advise how (or if) a medication can be safely given covertly – e.g., “Crush tablet and mix in spoonful of yogurt” or “Use liquid form in juice” or “Do not mix with hot tea,” etc. They’ll also advise on each medicine individually; sometimes only one or two meds need to be covert, not the whole regimen.
   • The views of family or those who know the person: maybe the person previously said “If I ever lose my mind, don’t let me be pumped full of drugs” or conversely “Do whatever it takes to treat me.” These past wishes (if known) weigh heavily. Also, family might suggest practical tips – like best foods to hide meds in that the person won’t detect, or timing when the person is more amenable.
   • We also consider the potential distress to the person: if they discover medication in their food, could it erode trust? Are we prepared to manage that and still justify it? Sometimes it’s needed (e.g., severe psychosis where person is paranoid of meds).
3. Decision and Documentation: If consensus (or at least a clear rationale) emerges that covert administration is in the person’s best interests, this must be clearly documented in the care plan and specifically in a “Covert Medication Plan.” Document who was involved in the decision (names of doctor, pharmacist, family, staff), the medications approved for covert administration, and the agreed method for each (for example: “Crush tablet X and mix into a full bowl of apple sauce – bitterness masked; open capsule Y and mix contents in yogurt; do not mix medication Z with food because not safe, will inject instead” etc.). Also document that alternatives were considered and why they won’t work. The plan should also state that this is being done without the person’s knowledge and why that’s necessary (e.g., “Person repeatedly refuses due to delusional belief it’s poison, and lacks capacity to understand reality of need”).
4. Authorisation: The covert medicines plan must arise from a properly documented Mental Capacity Act best-interest decision. The prescriber must confirm that the medicine remains clinically appropriate and the pharmacist must provide advice where altering, crushing or mixing a medicine may affect its safe administration. Care staff must not commence covert administration on their own initiative. Care staff must not decide to give any medicine covertly without this clear authorisation in the care plan. The prescriber’s involvement is crucial because altering a medicine’s form (crushing, etc.) can be considered off-label administration – they need to approve it.
5. Regular Review Date: The covert plan should have a review date set. Generally, covert medication use is reviewed at least every few months, or sooner if condition changes. For example, “Review covert plan in 3 months or sooner if [Person]’s understanding or compliance changes.” The plan should outline triggers for review – e.g., if the person starts willingly taking medicine, obviously covert practice stops. Or if a new medicine is added, need new pharmacist advice and update plan.

Administering Covertly:

• Only the medications that have been agreed in the plan are given covertly, and exactly in the manner described (for example, if the plan says mix in yogurt, don’t switch to juice one day because you ran out of yogurt – the medium matters due to taste and chemistry; consult pharmacist for any changes).
• Continue to try open administration first at each round if possible. Sometimes people have lucid moments or better mood where they might accept medicine normally. The covert plan doesn’t mean we automatically hide it every time without trying. It means we can hide it if the person is refusing and still not understanding.
• Keep track of how the covert administration is going. If the person regularly finishes the entire food/drink with hidden medicine, good. If they start to become suspicious (e.g., “This pudding tastes funny” or refusing food), that complicates things – notify the team, as we might need to adjust strategy or re-evaluate the approach. We may need to involve a speech and language therapist or dietitian if texture/taste is an issue (they can sometimes suggest strong-flavored foods to mask bitterness or flavor).
• Staff caution: Only the staff who have been trained in the covert plan should carry it out. They should know the signs to watch (ensuring full dose consumed, and not leaving it unattended where partially consumed etc.). They also ensure no one else consumes that food by accident (like if in a communal fridge, label it clearly as not for others).

Recording Covert Administration:

• On the MAR, doses given covertly are recorded as normal (as “given”). However, we often annotate “(covert)” next to it or in a separate record to indicate it was hidden – this way, all staff know this dose was administered disguised.
• Some services use a covert medication administration record, or at least note it in daily logs: e.g., “08:00 – Medication X given in porridge covertly as per plan, consumed full portion.”
• If the person only partially ate or drank the medicated food, this is tricky: we must estimate how much of the dose they likely got and inform the GP. E.g., “Only half of the yogurt was eaten – uncertain if full dose taken.” This might require advice on whether to reattempt or skip till next dose, depending on medication. Document such incidents thoroughly and inform the manager/GP as needed.

Ethical and Safeguarding Oversight:

• We treat covert medication as a form of last-resort restraint (chemical/restraint by deception). Therefore, it is reported to and scrutinized by management and potentially external bodies. For instance, our internal governance will track how many people are on covert meds and ensure reviews. The local authority or safeguarding teams might be informed if covert is initiated, to ensure it’s done in line with MCA (some areas require a formal best interest form copy sent).
• If at any point covert administration is being done outside of a proper plan (e.g., a staff member did it on their own accord), this is a serious misconduct and a safeguarding incident. We absolutely forbid that. Staff are trained that giving medication secretly without authorisation = abuse.
• Likewise, if covert is authorised, it is only authorised for specific meds. Staff cannot extend it to other medications without repeating the decision process. For example, just because covert is approved for an antipsychotic doesn’t mean one can also start hiding a vitamin pill – everything needs its own consideration (though some minor things might be included at once).

If Covert Administration Fails or is Challenged:

• Sometimes, despite covert efforts, the person might still refuse (e.g., they might notice or just coincidentally also refuse food). In such cases, the best interest team might reconvene to consider alternatives – possibly involve specialist services or consider if the treatment is absolutely necessary. In extreme scenarios (like a life-threatening refusal), legal advice may be sought about court of protection involvement or using the Mental Health Act if applicable (for example, giving treatment under MHA if in hospital). However, in supported living, we typically wouldn’t go that route without moving to a clinical setting.
• If a family or advocate challenges a covert plan (say one family member doesn’t agree), we try to mediate but ultimately may need a best interest decision via the Court of Protection if no agreement. That’s rare, but we note it as a possibility. Meanwhile, we act in the interim as safely as possible.

Important: Covert administration is not the same as giving medicines in a disguised way for someone who has capacity just because they don’t like taking pills. For example, if someone with capacity says “I hate the taste of that syrup, can I have it in juice?”, that’s not covert (they know it’s in the juice). That’s an acceptable compliance technique. Covert specifically means the person is unaware that a medicine is present. We always prefer the person to be aware and cooperative if possible, even if it means mixing with food with their knowledge. Only when they cannot understand the significance do we hide it.

Our adherence to these strict guidelines means any covert medication practice in our service is in line with the Mental Capacity Act Code of Practice and NICE guidance – protecting both the person receiving the medicine and our staff legally and ethically. The goal is to ensure the person’s health is managed in their best interests while minimizing infringement on their rights. Covert medication decisions will be regularly reviewed to see if it can be stopped (for example, if the person’s condition improves or a different approach is found). It’s a remedy of last resort, never taken lightly.

12. Controlled Drugs

Controlled Drugs (CDs) are medications that are subject to special legislative controls under the Misuse of Drugs Act 1971 and associated regulations, due to their potential for abuse, misuse or addiction. Examples of controlled drugs commonly encountered in social care include strong painkillers like morphine, fentanyl, oxycodone; sedatives like diazepam or midazolam; and stimulant ADHD medications like methylphenidate. These drugs can be extremely beneficial for health when used correctly, but they carry higher risks if not handled properly. Our service follows stringent procedures for managing controlled drugs to ensure safety, legal compliance, and accountability.

Receipt of Controlled Drugs:

• When a controlled drug is delivered from pharmacy, staff receiving it must be extra vigilant in checking the details. We verify the quantity and strength delivered against the prescription. Any discrepancy is reported immediately to the pharmacy before the driver leaves, if possible, or as soon as noticed.
• We record the receipt of the CD in a Controlled Drug register or log. In supported living, this might be a bound controlled drug book kept for the person (or for the service) where entries are made. We include date, what was received (drug name, form, strength, quantity), who it was received from (e.g., “XYZ Pharmacy driver”), and who received it (staff signature). The service user or a witness may also sign if appropriate. This creates an audit trail from the point of supply.

Storage of Controlled Drugs:

• All Schedule 2 CDs (e.g., morphine, methadone, fentanyl) and certain Schedule 3 CDs that require secure storage (like buprenorphine, temazepam) are kept under lock and key when stored in the service user’s home, unless the person is independently managing them and deemed safe to do so (this is rare for high-risk CDs, but possible if risk assessed). For most service users requiring controlled drugs, the medication will be stored in a small locked box or cupboard in their home, to which staff have access when needed.
• The storage container for CDs should be robust and secured (e.g., a metal cash box secured inside a drawer or a locked medicines cupboard attached to a wall). Only authorized staff and the individual (if appropriate) have access to the keys.
• We do not generally need a separate “CD cupboard” as in care homes; the person’s own locked cupboard suffices, but we treat it with the same level of security as a dedicated CD cabinet. If the person has multiple carers or lives with others, this locked storage is essential to prevent anyone else from taking the medication.
• Schedule 4 and 5 CDs (like weaker benzodiazepines, codeine, etc.) do not legally require lock-up, but as a precaution, we often store them securely too, especially if there are any concerns. It’s better to err on the side of caution.

Administration of Controlled Drugs:

• Whenever a controlled drug is administered by staff, we follow a two-person check when possible. In a supported living outreach scenario, having two staff present for every administration might not be feasible; however, for especially high-risk meds or high doses, we try to arrange double-checks (e.g., a second staff on site, or a phone verification if allowed by policy). At minimum, the administering staff double-checks against MAR and label meticulously (the 5 rights and perhaps an independent mental run-through: “Is this absolutely correct?”).
• We encourage service users to be involved: some might themselves count or check the dose with us, if capable. For example, “Mrs. X, I’m giving you one patch, we have 4 left after this.”
• After giving a CD, the staff immediately records the dose on the MAR (as usual) and also logs it in the Controlled Drug register. The register entry for administration includes: date and time, name of person, what drug and dose given, balance remaining, and staff signature. Ideally, a witness signature as well, but again, if alone, we ensure at least one signature is there and perhaps have a second staff verify later. For example, next staff to visit might count and co-sign that count.
• Witnessing: In settings with two staff, one gives the med and the other witnesses the whole process and co-signs the register/MAR. This greatly reduces errors and diversion. In single-staff contexts, we might implement periodic audits where a manager or second staff will randomly count and sign off the register to confirm the balance is correct.

Monitoring and Record-keeping:

• We maintain a running balance of each controlled drug in the register. Every time some is given or disposed of, the remaining quantity is updated. For example: “Morphine sulfate 10mg tablets – Received 30 on 1/11, gave 1 on 2/11 (balance 29), gave 1 on 3/11 (balance 28)…” etc. This ongoing count helps detect any discrepancies quickly.
• The MAR chart will also reflect doses given, but the CD register is a more detailed legal record. It is kept securely (usually locked in the same box or in the staff office if that exists on site). It’s separate for each service user or at least separated by sections, to avoid confusion between people’s stocks.
• We periodically reconcile the physical count of each controlled drug against the register balance (often weekly or each visit, depending on frequency of visits). For example, if the register says 10 remaining tablets but we count 9, that’s an immediate red flag – investigate for any missed entry or potential loss. If we count 11 (rare, but maybe a tablet got stuck in packaging and not given?), also investigate. Ideally, balance should always match.

Discrepancies or Incidents Involving CDs:

• If a controlled drug count doesn’t match or a dose goes missing (e.g., dropped and can’t be accounted for, or suspected theft), report it immediately to the Registered Manager. We will carry out an investigation. Sometimes simple errors (like forgetting to sign the register for a dose) cause temporary panic but are resolved. But any possibility of actual diversion (theft) or significant error (gave double dose by mistake) is treated seriously.
• Notify Authorities: By law, certain CD incidents must be reported. For example, lost or stolen CDs should be reported to the police and the local NHS Controlled Drugs Accountable Officer (CDAO). The Care Quality Commission also expects notification if the incident meets their criteria (which, for CDs, usually if police involved or harm caused). We have contact details for the regional CDAO and will inform them of any serious concerns or patterns (e.g., staff suspected of diversion).
• We will also consider any CD incident a potential safeguarding issue if it impacts the service user (like if someone deliberately withheld or tampered with a CD, that’s abuse). So local safeguarding procedures might be triggered in parallel.

Special Administration Considerations:

• Controlled Drug Patch (e.g., Fentanyl patch): When applying, two staff verify old patch removal and new patch placement if possible. We record the patch location on the body (rotating sites). Used patches still contain drug, so we fold them and dispose (with witness) safely – preferably returning to pharmacy or in a sharps/bin as per guidance, not just bin.
• PRN Controlled Drugs: If someone has, say, morphine oral solution as PRN for severe pain, each offer and administration must be recorded as above. And if “when required” we make sure the max dose in 24h is noted and not exceeded.
• Self-Administration of CDs: Generally, if a person is deemed able to self-administer a CD (rare for strong ones, but perhaps something like a mild codeine painkiller), a risk assessment is done. They might keep only a small quantity on them, with staff holding the rest, to mitigate overdose risk. Any such arrangement must be clearly in the care plan and agreed by the prescriber as well.

Disposal of Controlled Drugs:

• When controlled drugs are no longer needed (e.g., dose changed, or person passes away, or the medicine expires), they require special disposal. We do not throw them in regular trash. Instead, we return them to a pharmacy for destruction. We document in the CD register the quantities returned and get a receipt or the pharmacist’s signature if possible. For example, “Returned 5 tablets to XYZ Pharmacy for destruction on 10/12, signed by Pharmacist [Name]. Balance now 0 – medication discontinued.”
• If a tablet is partially wasted (e.g., half tablet due to dose adjustment) or a liquid drawn into syringe but not used fully, we dispose of that safely (usually by denaturing or mixing with an undesirable substance, per pharmacy guidance, before bin). Ideally, any wastage is witnessed by a second staff and recorded (like “1 tablet dropped and rendered unusable, disposed, witness [Name]”).
• We keep records of disposal to have a paper trail in case of any audits by regulators.

Staff Training and Authorisation:

• Only staff who have been trained in handling controlled drugs and understand the extra requirements are allowed to administer them. They must be aware of the legal implications – mishandling CDs can lead to criminal charges, not just internal discipline. We instill that sense of responsibility.
• They’re trained on signs of misuse or diversion – for instance, if a service user might be stockpiling or a staff member acting strangely around CDs (though we trust our staff, we remain vigilant because diversion is a known risk in healthcare).

Audit:

• Controlled drugs are a focus in our medication audits (Section 17). We check that all CD registers are up to date, balances correct, and that any anomalies are addressed. Senior staff might do unannounced counts. This oversight ensures continuous compliance and quickly flags any issue.

By managing controlled drugs with these robust processes, we ensure we meet regulatory expectations for safety and accountability. Regulation 12 (Safe care) explicitly encompasses the safe management of medicines, and controlled drugs are often scrutinized under that. Adhering to these procedures also aligns with the Misuse of Drugs Regulations and CQC’s guidance on controlled drugs in adult social care. The ultimate aim is to allow service users who need these powerful medications to receive their therapeutic benefit without undue risk – protecting them, other people in the environment, and staff from potential harm or legal breaches.

13. Self-Medication and Risk Assessment

Promoting self-medication is a core principle in supported living, as it fosters independence, autonomy, and confidence in managing one’s own health. Many individuals, even with disabilities or health conditions, can safely administer their own medications with the right support in place. Our policy is to enable and support service users to manage their own medicines whenever possible, provided it is safe to do so. To achieve this, we use thorough risk assessments and individualized plans.

Initial Assessment of Ability:
When a person joins the service or when a new medication is introduced, the keyworker or a trained staff member, under the manager’s guidance, will assess the person’s capacity and capability to self-administer. This assessment looks at:

• Cognition and Memory: Does the person understand what each medication is for and the importance of taking it correctly? Can they remember to take it at the right times? We might ask them to describe their routine or do a trial where they demonstrate how they would manage. For someone with mild memory issues, they might still manage with aids (alarms, pill organizers). For someone with significant dementia, self-medication likely isn’t feasible.
• Physical Ability: Can the person physically handle the medications? This includes opening bottles or blister packs, handling small tablets (arthritis or tremors can interfere), using inhaler devices properly, or applying creams to reachable areas. If they have a physical disability (like limited hand function or vision impairment), can adaptations help? Large print labels, easy-open caps, or assistive devices can sometimes bridge the gap. If a person is blind, they might still self-medicate if everything is organized consistently and perhaps labeled in braille or by tactile markers – with training, this can work. We consider these adjustments in the assessment.
• Mental Health Considerations: For those with mental health needs, is their condition stable enough to manage meds? Someone with severe depression might neglect doses; someone with psychosis might have delusions about pills. We gauge how their condition affects reliability. Perhaps they can do it on good days but not during a crisis. We might plan for partial support accordingly.
• Risk of Misuse or Accidental Harm: This is crucial. If a person has a history of substance misuse or might impulsively take more than prescribed (due to confusion or intentional overdose risk), self-administration would be high risk. Similarly, if they have suicidal ideation, holding a month’s worth of medication (some of which could be lethal in overdose) is dangerous. In such cases, we limit quantity accessible or require staff admin. The assessment will note if there’s any such risk factor.
• Understanding of When Not to Take: Self-administration includes judgment calls – e.g., “as-needed” meds or deciding not to take a PRN if not needed, or recognizing a missed dose and what to do. We check the person’s knowledge. If they might accidentally double dose because they forgot they took it, that’s a risk (though pill boxes with day slots can help indicate if already taken).

Graded Levels of Self-Medication:
Self-medication isn’t all-or-nothing. We often use a graded approach:

• Level 1 – Full Self-Administration: The person stores and takes their medications independently. Staff role is minimal – perhaps only to periodically check if they are managing or to reorder prescriptions.
• Level 2 – Self-Administration with Prompting: The person is in control of taking the meds, but staff provide reminders at scheduled times. For example, staff might call or visit to say “It’s time for your medication” and then watch to ensure they take it, without staff handling the meds. This is often employed if memory is the only issue. It’s still essentially self-medication because the person takes it themselves after being reminded.
• Level 3 – Self-Administration with Physical Assistance: The person can direct their own medication but needs help with the physical act (opening bottles, etc.). Staff assist with those tasks but the person actually takes the medicine themselves, understanding what it is. For instance, a person might say “Please open this inhaler for me and hold it, I’ll inhale it.” This blurs with “administered by staff,” but if the person is clearly in charge and just needs a hand, we treat it as assisted self-administration. The person should ideally confirm each time what they are taking and why, reinforcing their control.
• Level 4 – Staff Administration with Consent: This is when the person has decided or agreed they want staff to manage it (perhaps they find it too stressful or have a slight cognitive impairment that makes them prefer staff handle it). It’s not truly self-medication, but the person’s consent is there. We routinely revisit whether they want to try more independence.

The care plan will explicitly state which level or combination is in place for each medication. It might be that for some simple meds the person does it, but for a complicated one (like injections) staff do it. That’s fine.

Support and Education:
To help someone self-medicate, we offer support such as:

• Education about their medicines: In simple, appropriate language, we teach them what each pill is for, when to take it, and what happens if they skip or overdose. Pamphlets, flashcards, pill diaries can be used. If the person knows why a med is important (e.g., “this prevents your seizures” or “this inhaler opens your lungs so you can breathe easier”), they’re more likely to remember it.
• Tools: Provide or recommend aids: pill organizers (if safe – note that NICE says monitored dosage systems should only be used if assessed, but a simple day-of-week box might help some people keep track), alarms or phone reminders, dosage calendars, etc. Some pharmacies fill blister packs by day/time which can help self-admin (but again, only if needed and after assessment, because those packs also have downsides like lack of flexibility for PRNs).
• Safe Storage at Home: If they self-administer, they keep meds ideally in a safe place known to them. We encourage locking it away if others could access, but if the person themselves might forget where a key is or has dexterity issues, we adapt (maybe a drawer out of reach of visitors but not locked, etc.). It’s a balance between their autonomy and general safety.
• Regular Check-Ins: Even with independent clients, staff will periodically (say weekly or at each visit) ask how it’s going: “Have you been taking your tablets okay? Let’s see, you had 28 at the start of the week, there should be 7 left today if all is well.” This is not to police them, but to monitor adherence gently and catch any issues. If we find discrepancies – like too many left (meaning missed doses) or too few (could indicate double dosing or taking more than prescribed), we’ll address it. Not in a punitive way, but problem-solving: if missed, why? Forgot? Side effects making them skip? If too few, did they take extra for more pain? That might mean their pain isn’t controlled, time to see GP. We keep notes of these check-ins.
• Adjust Support as Needed: If someone is struggling with self-administration (lots of missed doses or mistakes), we might increase support level temporarily (more prompting or partial help) while we try to resolve underlying issues. Conversely, if someone is doing well, we might step back further (maybe shift from staff bringing meds daily to the person handling a week’s supply by themselves). Changes are always risk-assessed and agreed with the person and relevant professionals.

Risk Assessment Documentation:
We have a Medication Self-Administration Risk Assessment form for each person who self-medicates, covering all the points above. It will conclude one of three outcomes generally: independent (with any aids noted), needs some support (prompt/assist), or not safe to self-administer (full staff admin). It also notes if there are specific restrictions, e.g., “Service user can manage all except controlled drugs, which staff will administer due to safety reasons.”

We also include contingency plans: e.g., “If [Name] forgets more than 2 doses in a week, staff will increase visits to assist and notify GP,” or “If [Name]’s mental state deteriorates (per relapse indicators), staff will temporarily take over medication administration to ensure continuity, under best interest until recovered.”

Special Scenarios:

• If a person goes on home leave or holiday, and they normally have staff administer, but on holiday they want to self-manage, we’ll do a fresh risk assessment for that context. Maybe they can with family help. Or we pre-pack the required doses for them (like in envelopes per day) if they can manage that way.
• If a person has fluctuating capacity (like intermittent confusion), we might have an arrangement that on clear days they do it, on confused days staff step in. This requires very attentive staff who can gauge capacity day by day and is challenging, but we try to involve the person as much as possible.
• Emergency medications: Sometimes a usually independent person might need help in an emergency (like during a mental health crisis or after a hospital visit when they’re weak). The plan should allow flexibility that staff can take over temporarily if needed, with consent or best interest as appropriate, to tide over the crisis.

Benefits of Self-Medication:
We emphasize to staff that enabling self-medication is beneficial for the person’s dignity and skills. It’s part of meeting the Regulation 9 requirement for person-centred care – respecting the person’s right to control their daily life as far as possible. It also can improve health outcomes, as people who manage their own meds often have a better understanding of their conditions and adherence in the long term.

Ongoing Monitoring and Review:

• We review the self-medication risk assessment at regular intervals (for example every 6 months, or sooner if any incident/changes). The review might involve asking the GP or family for input if any concerns arose.
• If there have been any errors or close calls while on self-administration, we might decide to adjust the plan. For instance, if a person accidentally took an extra dose one day, we might re-educate them and perhaps implement a daily or multi-day pill box to prevent recurrence.
• Conversely, if someone has been stable and wants to try more independence, we’ll cautiously trial it. For example, a person who had staff calling daily to remind might try using an alarm on their own for a month while staff reduce calls, then fully stop if all goes well.

All these efforts align with the guidance that supported living services should support people to manage their own medicines where possible, considering their wishes and abilities. It also supports the wellbeing principle of the Care Act 2014, enhancing individual control over health. By balancing risk and independence through careful assessment and support, we help service users maintain their skills and confidence, making medication management a collaborative part of their daily living rather than an imposed task.

14. Record Keeping (MAR Charts and Communication)

Accurate and thorough record keeping is an integral part of safe medication management. Our service maintains detailed records for all medication-related activities, both to ensure continuity of care and to demonstrate compliance with legal requirements (Regulation 17: Good Governance). The primary tool for this is the Medication Administration Record (MAR) chart, complemented by other documentation such as care plans, daily notes, and communication logs. This section outlines our practices for medication record keeping and the communication protocols related to medicines.

Medication Administration Record (MAR) Charts:

• A MAR chart is prepared for each service user, listing all the medications that we support them with – including regular (scheduled) medicines, PRN (as-needed) medicines, and any short-term courses (like antibiotics). Each MAR entry includes the name of the medication, the form (tablet, cream, inhaler, etc.), the strength (e.g. 5mg), the dose to be given at each time, the route (oral, topical, etc.), and the timing/frequency (e.g. 8 AM and 8 PM daily, or “twice a week on Mon/Thu”). It also contains the prescriber’s directions like “with food” or “before bed” if applicable. We also note the person’s GP practice name on the MAR, any allergies, and often have their photo on file to avoid identification errors.
• MAR charts may be in paper format or electronic (eMAR) depending on our system. Either way, staff are trained in their use. Paper MAR sheets for a month are usually printed or written at the start of the cycle based on the latest prescription, and double-checked by a senior for accuracy against the prescription. Electronic MAR requires staff to log in securely. We ensure MARs are up to date whenever there is a medication change.
• Recording Doses: Every time a staff member administers, assists, or observes a medication being taken, they immediately record it on the MAR. This includes: placing their initials or signature in the box corresponding to the date and time, or selecting the appropriate option on eMAR. We never pre-sign or pre-mark doses in advance (that would be falsifying records). If a dose is not given exactly at the scheduled time (say it’s given 30 min later due to a slight delay), it’s generally still signed in that time slot with no issue, but if a significant delay or early administration, we might annotate a note.
• Codes for Non-Administration: MAR charts have standard codes to explain why a dose was not given as prescribed. For example: “R” for refused, “O” for omitted (with reason), “H” for hospital (if person away), “S” for self-administered (if they took it themselves without staff, but we log that), etc. We use these codes accurately. If a code is used, staff add a brief explanation in the notes section (e.g. “R – refused, complained of nausea – will try later” or “O – not in, at day centre”).
• Documentation of PRN Usage: As discussed in Section 10, when a PRN dose is given, staff record it on the MAR and also document the reason and outcome. Some MAR charts have a backside or separate PRN sheet for recording details like time, reason, and effect. We ensure that if someone audits the MAR, they can tell why PRN was given and whether it helped.
• Transcribing Changes: If a GP changes a dose or stops a medication mid-cycle, we update the MAR accordingly. Ideally, we get a new MAR printed. If not, a clear line is drawn through the old direction with “stopped on [date]” noted, and a new entry is written for the new dose, signed and dated by the staff making the change. We always require a written direction (prescription or at least an email/fax from GP) to make MAR changes – never just verbal. Two staff should verify any hand-written addition on a MAR for safety.
• MAR Chart Accuracy: The manager regularly audits MAR charts for completeness and accuracy. Any gaps (unsigned entries) are investigated – the staff is asked if they forgot to sign or if the dose was actually omitted. Patterns of missed signatures lead to retraining. MARs are legal documents and could be reviewed by regulators, so we maintain them carefully.
• Completed MAR charts (paper) are archived for a set period (usually 3 years) in line with guidance, securely, since they are confidential records. eMAR data is stored in the system likewise.

Daily Care Notes and Communication Logs:

• In addition to MAR, staff often write in the person’s daily care notes about how the medication support went if there is something noteworthy. For example, “Morning: Took all medications with no issues,” might not need noting if routine, but “Evening: Refused blood pressure tablet, will try again in 1 hour” would be noted, or “Complained of dizziness after meds – advised to rest, will monitor.” This provides context that might not all fit on MAR.
• If any communication with healthcare professionals occurs (like called GP about a med question, or pharmacist clarified something), staff record this in a communication log or the daily notes, including the date/time and outcome. For example, “01/11, 10:00 – Phoned Dr. Jones about rash possibly from new antibiotic; he advised to stop med and will prescribe alternative. Noted to MAR and awaiting delivery.”
• When a person goes to a hospital or other setting, we send a Medication Administration Record or list with them so that facility knows what they’re on. We also note in our records what we sent (to ensure everything is accounted for on return). On discharge, we update MAR if hospital changed anything.

Handover and Verbal Communication:

• In any service where multiple staff shifts attend to medication, an effective handover system is crucial. Staff verbally (or via a written handover sheet) communicate any medication issues to the next staff. For instance, “She refused her lunchtime dose, please keep an eye and try to give it if possible when you come in the afternoon,” or “I gave the last dose of her eye drops this morning, new bottle is in order – please ensure pharmacy delivers tomorrow.” We aim to ensure no critical information is lost between shifts.
• We also communicate with service users about their medication. If a dose was missed or changed, we explain to them too (if they have capacity) as part of transparency.

Multi-Disciplinary Communication:

• GPs and Pharmacists: We maintain open lines with GPs – sending medication administration records or updates if required. If a person is having frequent PRN use, we might fax or email a summary to the GP before an appointment. Pharmacists are consulted for any queries (like can two meds be taken together, or can this pill be crushed, etc.). Those consultations are then recorded as mentioned.
• Families: With consent, we inform family members about medication changes or incidents. For example, if an elderly parent refused meds a couple times, the daughter might want to know to encourage them. Or if a new med started, family should be aware to watch for side effects. We respect confidentiality and only share what’s appropriate and agreed, but since medication is a key part of care, keeping families in the loop (when the service user wishes) can improve adherence and support.

MAR and Confidentiality:

• MAR charts contain personal health information, so we keep them confidential and secure. In a service user’s home, the MAR (and any paper records) are kept in a confidential manner – either in a folder on a shelf known to staff and the person, or a locked cabinet if required. We make sure visitors or other clients can’t easily read someone’s MAR. Electronic records are password-protected. This aligns with Data Protection (see Section 20).
• After each medication round or visit, staff ensure the MAR is stored away – not left open on a table. If our staff do not stay on site (e.g., if it’s an outreach call), the MAR might be kept in the service user’s care file at their home or sometimes brought back to office – depending on arrangements and the person’s preference. We balance having records accessible to staff when needed and keeping them safe from improper access. Many supported living setups keep a folder in the person’s home for care notes and MAR, which staff bring and put away discreetly.

Documentation of Medication Changes and Reviews:

• We keep records of all medication reviews (as per Section 15). If a medication review meeting happens, we file any notes or new medication lists that come from it, and update MARs accordingly. If the GP issues a new list, we compare it to our MAR to ensure accuracy.
• If we receive hospital discharge summaries with medications, we double-check them against current MAR and make necessary changes. Those summaries are stored in the care record as well.

Auditing Records:

• The Registered Manager or delegated senior conducts regular audits of MAR charts and medication records. They look for completeness, legibility, and any signs of misadministration or transcription errors. They also ensure that every medication in the care plan has a matching MAR entry and vice versa – consistency is key. Outcomes of audits (like identifying that a certain code was overused without explanation) lead to corrective actions (like retraining or updating procedures).
• As part of governance (Reg 17), we might summarise monthly how many med errors occurred, how many refusals, etc., to identify any trends to address.

Delegated Healthcare Tasks

Where a healthcare professional delegates a medicines-related healthcare task to a member of {{org_field_name}} staff, the task will only be accepted where it is appropriate for the service, the individual staff member and the person’s assessed needs.

Examples may include insulin administration, blood glucose monitoring, administration of medicines through an enteral feeding tube, specialist rescue medication or other person-specific clinical tasks.

Before a delegated healthcare task is undertaken:

• the delegating registered healthcare professional must confirm that delegation is appropriate;
• clear written instructions and a person-specific protocol must be available;
• responsibilities and accountability must be clearly agreed;
• the member of staff must receive task-specific training;
• competence must be assessed and documented by an appropriately qualified person;
• staff must understand the limits of the delegation and when to seek clinical advice;
• necessary equipment and infection-control arrangements must be available; and
• the task must be included within the person’s care plan and risk assessment.

Competency will be reassessed at intervals determined by the delegating professional, following significant changes to the person’s treatment, after relevant incidents or where concerns about staff competence arise.

Staff must not undertake a delegated healthcare task for which they have not been trained, assessed and authorised.

Use of Technology:

• If using an eMAR system, it may have features like alerts for missed signatures or real-time updates accessible to managers. We utilise those features – e.g., manager gets an alert if a dose wasn’t signed off by certain time, so they can follow up promptly.
• However, we ensure technology doesn’t replace human diligence – staff still need to think critically and not just click through prompts.

Communication Regarding MAR to External Auditors or Inspectors:

• We ensure that during CQC inspections or any external audits, up-to-date MAR charts are readily available and well-organized for review. Inspectors often check a sample of MARs to see if any doses were missed or if codes are properly used. Our goal is that they find our records comprehensive and transparent, reflecting good care.
• We also would show them any supporting records (like incident forms for any errors and what actions taken – demonstrating our duty of candour and improvement steps).

In essence, robust record keeping ties everything together: it provides evidence that medications were given (or reasons why not), and it ensures information is communicated across all those involved in the person’s care. It is a cornerstone of safe treatment and good governance. As the saying goes, “if it’s not documented, it didn’t happen.” We take that seriously – every important action or decision regarding medication is recorded in the appropriate place. This protects the service user (continuity and safety), the staff (medico-legal protection by having a clear log), and the organization (demonstrating compliance with CQC’s expectations for documentation and communication).

15. Medication Reviews

Regular medication reviews are essential to ensure that each service user’s medication regimen remains safe, effective, and tailored to their current needs. Over time, people’s health conditions can change, they might develop side effects, or some medications might no longer be necessary. By facilitating medication reviews, our service complies with the principle of providing effective and appropriate care (Regulation 12: Safe care and treatment) and the expectations of the Care Act 2014 in promoting wellbeing (ensuring people aren’t on unnecessary or harmful medications).

What is a Medication Review?
A medication review is a structured evaluation of a person’s medications (prescribed, over-the-counter, and supplements) with the aim of optimizing the impact of drugs while minimizing related problems. It is usually conducted by a healthcare professional, such as a GP, pharmacist, or specialist, and should ideally involve the service user (and their family/carer if appropriate). The review looks at things like: Is each medication still needed and providing benefit? Are the dosages correct? Are there any duplications or interactions? Can any medication be reduced or stopped? Are there cheaper or simpler alternatives? Are monitoring tests up to date (like blood tests for certain drugs)?

Frequency of Reviews:

• For older people (65+) and those on multiple medications (polypharmacy), annual medication reviews by the GP are generally recommended as a minimum. Our service will liaise with the GP to ensure these are scheduled. Often, GP practices do an annual review around the person’s birthday or another set month. We keep track and remind the GP if needed.
• For individuals with complex regimes or high-risk medications (like warfarin, lithium, insulin, antipsychotics), reviews may be more frequent or with specialists. For example, a psychiatry review every 6 months for someone on antipsychotics, or a diabetic clinic review for someone on insulin quarterly.
• After major health changes (e.g., a hospital admission, a new diagnosis, significant weight change affecting dosages, or after any adverse drug reaction), an ad-hoc review is arranged promptly rather than waiting for the routine schedule.

Our Role in Medication Reviews:

• Preparation: As care staff, we often have valuable insight into how medications are affecting the person day-to-day. Prior to a review, we gather relevant information: MAR charts showing adherence, any noted side effects (e.g., “Service user has been more drowsy in mornings since starting drug X”), PRN usage logs (how often they needed extra meds), and the person’s own feedback (“I don’t like taking that big pill” or “I feel better now, do I still need all these?”). We may fill out a medication review template provided by some GP practices or write a short summary to provide to the GP or pharmacist.
• Involvement: We support the service user to attend the review appointment. This could mean a staff member accompanies them to the GP or pharmacy if needed, or arranges a home visit by the GP/pharmacist. We encourage the person to voice their experience (“I think that tablet upsets my stomach”) but also help articulate issues they might not realize are related to meds (“We’ve noticed you’ve been a bit unsteady; wonder if it’s your blood pressure tablets making it too low”).
• During the Review: If present, our staff provide accurate information about administration and compliance. For example, “He missed quite a few doses of the afternoon pill because he goes out – is it possible to change it to once daily or a long-acting version?” or “She’s taking PRN painkillers almost daily – maybe her arthritis pain isn’t well-controlled with the current regimen.” This input can significantly guide the prescriber’s decisions (for instance, maybe a regular pain med should be added instead of frequent PRN, or an alternative treatment considered).

Outcomes of Reviews:

• The GP or reviewing pharmacist might decide to stop some medications that are no longer needed (deprescribing). For example, stopping a vitamin supplement after levels normalized, or discontinuing one of two drugs if they were duplicative. They could also decide to add or substitute medications (e.g., replace one blood pressure pill with another that has fewer side effects, or add a bone protection tablet if on long-term steroids).
• They may adjust doses – perhaps reducing a sedative that was causing drowsiness, or increasing a dose if condition not controlled.
• They will check for any needed monitoring: e.g., ensure blood tests for thyroid if on thyroxine, or kidney function tests if on certain meds. Our staff should note if any such tests are requested so we can facilitate them (like taking the person for a blood draw).
• Another outcome is reinforcing instructions, e.g., “GP reminded to not take NSAID on empty stomach” – we’d reinforce this in care delivery.

Documentation and Communication Post-Review:

• Any changes from the review are documented in the care plan and the MAR chart is updated accordingly (with a new prescription from the GP). We often receive a medication review printout or list from the GP/pharmacy after the review; we file that in the person’s records as evidence and for reference.
• We ensure all staff are made aware of changes immediately. For instance, if simvastatin was stopped, an email or handover note goes out to all relevant staff and the MAR is crossed off for future doses. If a new med started, we add it to MAR and inform staff of any new side effects to watch for.
• We also inform the service user and family (if appropriate) of what changed and why, in plain terms: “The doctor has stopped your water tablet because it was making your blood pressure too low. They’ll see if you manage without it – we’ll monitor your weight and swelling as discussed.”

Follow-Up:

• After a change, we monitor closely. For example, if a dose is reduced to see if side effects improve, we observe if indeed improvement happens and also if the condition remains controlled. We report back to GP as needed.
• We encourage service users to give feedback: “Do you notice a difference after stopping that med?” and communicate that feedback to the prescriber if it’s significant.
• If the review introduced a trial (like “try without sleeping pill for a month”), we help implement that and report on outcomes (sleep pattern, etc.). Possibly the GP will have a follow-up appointment to evaluate the trial, which we’d facilitate.

Special Focus Areas in Reviews:

• Mental Health Medications: If supporting someone with mental health needs on psychotropics (antidepressants, antipsychotics, mood stabilizers), ensure there’s a plan to review efficacy and side effects regularly, ideally by a psychiatrist or GP. Over time, attempts should be made to taper off unnecessary psychotropics (aligned with STOMP principles for those with learning disabilities or autism, for example). If PRNs for agitation are frequently used, the review should consider non-pharmacological alternatives or adjustments.
• Physical Disability/Older People: They might be on many medicines (polypharmacy). Reviews should particularly look at simplifying regimens (maybe using combination pills), avoiding medicines that are on Beers criteria or similar (those potentially inappropriate for older adults causing falls, etc.), and checking if doses need adjusting for weight/kidney function. Our staff might highlight things like: “He struggles to swallow that large pill; can we get it in liquid?” or “She’s very sleepy, perhaps the two different pain meds together are too much?”
• Preventative Medications: Over time, risk-benefit can shift (e.g., statins in very old age, or aspirin therapy). The GP will consider if all preventatives are still indicated. We don’t decide those, but we watch if the person is reluctant (some older adults get pill fatigue and start refusing some preventatives) and raise that in reviews.

Involvement of Pharmacists:

• Sometimes a clinical pharmacist (from the GP practice or a commissioned service) might do a comprehensive medication review, especially if polypharmacy. They might even visit the person’s home to review how they manage meds (MUR – Medicines Use Review). We collaborate with them, providing MAR records or insight and implementing any recommendations they give (with GP sign-off as needed). Pharmacists often identify issues like interactions or unnecessary duplications that might have been overlooked.

Record of Medication Review:

• In the care plan, we maintain a section that notes the date of the last medication review, who conducted it, and key recommendations or changes made. Also, when the next review is due. This way, any staff or inspector can see at a glance that, for example, “Medication last reviewed by Dr. Smith on 5 Oct 2025, next review Oct 2026 or sooner if needed.” It’s an indicator of proactive care.

By ensuring medication reviews happen regularly and by actively participating in them, we help to prevent “medication creep” (where someone ends up on too many meds for too long), reduce adverse effects, and ensure each medication is serving a beneficial purpose. This is closely tied to person-centred care – we don’t want someone on a drug that no longer aligns with their health goals or conditions. It also meets CQC’s expectation that care providers support people with the optimisation of their medicines and involve relevant healthcare professionals to achieve the best outcomes.

In summary, medication reviews are a safety net and an opportunity for improvement in the medication management process. Our service treats them as a priority, not a formality, and always follows through on any actions arising from those reviews.

16. Training and Competency of Staff

To ensure safe medication management, it is imperative that all staff involved in handling medicines are properly trained and competent. The Care Quality Commission’s fundamental standards (Regulation 12 and Regulation 18) require that staff have the skills and knowledge to carry out their duties safely. Our service is committed to providing comprehensive training to staff and regularly assessing their competency in medication-related tasks. This section describes our training program and competency evaluation process.

Initial Training (Induction):

• Mandatory Medication Training Course: Every new care staff member must complete a medication training course as part of their induction before they are permitted to administer or even assist with medications unsupervised. We use a course that covers the fundamentals of medication management in social care, aligned with national standards (such as the Care Certificate medication module or an accredited vocational training). The content includes:
  • Understanding the legal context: the responsibilities of social care staff, the boundaries (e.g., only administering medicines as prescribed, not prescribing or altering doses themselves), awareness of regulations like the Medicines Act, misuse of drugs laws, and CQC expectations.
  • Different types of medications and their purposes (analgesics, antibiotics, psychotropics, etc.), including common side effects to watch for.
  • Forms of medication and routes: oral tablets, liquids, topical creams, inhalers, eye/ear drops, patches, injections (though in personal care we usually don’t do injections unless specifically trained for that person, e.g., insulin with specialized training). The training describes how to administer each form correctly (e.g., shake inhaler, apply eye drops without touching eye, etc.).
  • The “Five Rights” (or Six Rights) of medication administration and the importance of each.
  • Medication records: how to read and use MAR charts, proper documentation, common abbreviations (like OD = once daily, etc.), and what to do if instructions seem unclear.
  • Safe storage and disposal: reinforcing what staff need to do in clients’ homes, including safe handling of controlled drugs.
  • Infection control: e.g., hygiene when handling meds, using gloves for topical meds, not touching tablets with bare hands if possible.
  • Consent and capacity: reiterating that they must obtain consent, follow MCA for covert meds (with some scenarios or case studies). Emphasis that covert is last resort and must be authorized.
  • Handling errors: what steps to take if a mistake is made (report immediately, etc.), fostering an open culture (no cover-ups).
  • PRN protocols: understanding how to decide when to give PRN, how to record it, and monitoring outcomes.
  • Scenario practice: Many trainings include case studies or role-playing medication rounds to apply knowledge.
• Assessment after Training: At the end of the initial training, there is typically an assessment (could be a written test or practical observation) to ensure the staff has understood key concepts. We require a passing score. If someone struggles, they will get further coaching and must re-test. Only those who demonstrate sufficient knowledge progress to next steps.

Shadowing and Supervised Practice:

• After the theoretical training, new staff will shadow experienced staff on medication rounds. They observe how medications are checked and given, how MAR is filled, etc. This real-world observation helps consolidate the learning.
• Next, they move to supervised practice: the new staff administers medications under the direct supervision of a competent senior staff or the manager. The supervisor will watch and intervene or guide as needed. We usually mandate a certain number of supervised medication rounds (for example, on 3 separate shifts or until both feel confident). During these, we particularly ensure they practice different scenarios, including giving tablets, prompting a self-medicating client, dealing with a refusal, etc., to gauge their response.

Competency Assessment:

• The Registered Manager or a designated trained assessor will conduct a formal competency assessment before “signing off” a staff member as authorized to administer medication independently. This often involves an observed round where the staff is evaluated on a checklist: Did they check the MAR properly? Did they identify the right person and explain? Did they observe the person take it? Did they record correctly? Did they know what to do when asked a question? Perhaps a few oral questions thrown in (“What would you do if he refused just now?” or “Show me how you’d measure a liquid dose.”).
• If the staff is being assessed on specialized tasks (like administering via PEG feeding tube or insulin injection for a particular client – which rarely falls under personal care but if it does under our remit with appropriate delegation), specific competency tools are used for those skills as well with additional training by healthcare professionals.
• Only once the assessor is satisfied will the staff member be allowed to administer meds unsupervised. We keep a record of competency sign-off in the staff file, noting date, who assessed, and for what scope (e.g., “Competent for oral and topical medicines administration” – if something like insulin was taught separately by a nurse, that would be a separate competency sign-off).

Refresher Training:

• Medication competency will be formally reassessed at least annually and sooner following a significant medicines incident, prolonged absence from medication duties, introduction of a new specialised task or where concerns about competence arise.
• We require all staff to attend medication refresher training at least yearly (or every two years at maximum, depending on updates or if errors indicate sooner is needed). The refresher covers updates in policy, any new types of medications, reinforcement of practices, and learning from any incidents that have occurred. It’s also an opportunity to re-emphasize aspects like MCA, new NICE guidelines, etc.
• Additionally, if there are any changes in law or guidance (for example, a new controlled drug regulation or updated NICE guideline), we will incorporate that into ad-hoc training sessions or supervisions rather than waiting for the annual refresh.

Ongoing Competency Monitoring:

• Competency isn’t a one-and-done. We observe staff informally during spot checks or when working together. The manager might do random MAR audits and if a pattern (like one staff often has MAR errors) is noted, that staff gets a remedial competency assessment or additional training.
• We also include medication management in staff’s annual performance appraisals or supervisions. We might ask questions or discuss any difficulties they feel with medication tasks.
• If a staff member makes a significant medication error or a series of minor ones, we will require them to undergo retraining and re-assessment. For example, if someone gave a wrong dose, they’ll be taken off medication duty immediately, retrained, and then need to be re-evaluated before resuming.

Specialised Training:

• Some conditions/medications require specialized knowledge. For instance, for a client with diabetes on insulin, staff would get specific training from a diabetes nurse on insulin administration, blood glucose monitoring, signs of hypo/hyperglycemia and what to do. Only staff who have completed that training and been deemed competent can support that client’s insulin.
• Similarly, for epilepsy with rescue meds (like buccal midazolam for seizures), staff get training on how and when to administer emergency medication and safety precautions.
• For clients with mental health needs, staff may receive training in understanding psychotropic medications and managing side effects (like how to respond if someone has tremors from medication, or monitoring for lithium toxicity signs, etc.).
• We ensure training on the Mental Capacity Act and DoLS (now LPS) is done for all staff, but particularly emphasize scenarios of consent to treatment and covert meds as part of medication training as well.

Agency or Relief Staff:

• We hold agency/temporary staff to the same standards. Ideally, they should provide evidence of medication training. We still verify their understanding and may not assign them unsupervised med tasks unless we’re confident of their competency. If in doubt, a permanent staff handles the meds.
• If we use agency regularly, we might require them to undergo our competency check too.

Record of Training:

• We maintain a training matrix listing all staff and the dates of their med training, refreshers, and competency assessments. This is monitored so no one goes past due for refreshers. CQC often asks to see evidence of staff training in medication, so we have certificates or records on file.

Culture of Learning:

• We foster an environment where staff feel comfortable asking questions about medications. No one should ever administer something they are unsure about. They are encouraged to consult the manager, pharmacist, or reliable sources (like the medication’s information leaflet or the BNF) if they have questions. Part of competency is knowing your limits – e.g., if a staff can’t read a faint prescription label, they should get clarification rather than guess.
• We share learnings from any incidents or near misses in team meetings (anonymized as needed): “From last month’s incident where X was given late, what can we learn? Let’s all double-check times against care plans when schedule changes, etc.” This continuous learning helps sharpen everyone’s competence over time.

Medication Advice and Escalation

Staff must never guess when dealing with a medication concern.

The first internal point of contact is:

Registered Manager: {{org_field_registered_manager_first_name}} {{org_field_registered_manager_last_name}}
Telephone: {{org_field_registered_manager_phone}}
Email: {{org_field_registered_manager_email}}

Depending on the concern, staff may also contact the person’s GP, dispensing pharmacist, community nurse, NHS 111 or emergency services.

In an immediate life-threatening emergency, staff must call 999.

By ensuring robust training and competency checks, we make sure that staff “have the qualifications, competence, skills and experience to do so safely” when it comes to medications. This not only protects service users from harm but also gives staff confidence in their role, and families peace of mind that professionals are handling medicines. It’s a critical part of our governance that ties directly into safe outcomes. Remember: even the best-written medication policy is only as effective as the people implementing it, so we invest in our staff to uphold these standards every day.

17. Auditing and Monitoring

Continuous auditing and monitoring of our medication management practices help us maintain high standards, catch any issues early, and drive improvements. In line with Regulation 17 (Good Governance), we have systems in place to routinely check that our procedures are being followed and are effective. Audits provide accountability and assurance that service users receive their medicines safely and correctly every time.

Types of Medication Audits:

• MAR Chart Audits: On a weekly basis, a senior staff member or the Registered Manager reviews all completed MAR charts (or current ones if mid-cycle) for each service user. They look for:
  • Any missing signatures or gaps – which indicate a dose may have been missed or not recorded. If found, they investigate with the staff involved (was it an omission? Documentation error? If the dose was missed, was proper action taken?).
  • Accuracy of entries – checking that each medication listed on the MAR matches the latest prescriptions and care plan. If a new med was started but not added to MAR, that’s flagged to fix immediately.
  • Correct usage of codes – ensure that when a code (like refused or out) is used, there is an explanatory note. Also check if certain codes appear frequently (e.g., “refused” frequently at a particular time) and consider if a care plan adjustment or review is needed.
  • Legibility and completeness – MAR should be neat and not have unapproved alterations. Any alterations (like a dose change) should be countersigned properly.

Findings are documented, and any action needed is assigned (for example, “speak to John about why he left MAR blank on 2 occasions; retrain on documentation,” or “update MAR for Mary – GP increased dose on 10th, but MAR still showing old dose – done now”). The manager follows up to ensure these actions are completed.

MAR charts must be based on an authoritative source of current medication information, such as the pharmacy dispensing label, current prescription, discharge information or confirmed prescriber instruction. Staff must not make medication changes based on verbal assumptions, memory or unofficial information.

Where a handwritten or amended MAR entry is necessary, this may only be completed by staff authorised and competent to do so under the organisation’s MAR procedure. The source of the instruction, date, time and person making the entry must be recorded and, where required by organisational procedure, independently checked.

Discontinued or changed medicines must be clearly identified so that obsolete instructions cannot be followed accidentally.

• Medication Storage and Stock Audits: At least monthly (often more frequently for controlled drugs), we audit how medicines are stored and track their stock levels. This includes:
  • Checking each person’s medication storage area in their home (with permission) to ensure it’s secure, organized, and only contains current medications. Remove any expired or discontinued meds (to dispose properly).
  • For each medication, compare the remaining stock against what is expected based on MAR records. For instance, if 20 tablets were supplied and MAR shows 10 given, there should be 10 left. If discrepancies are found, investigate and resolve (it could be a recording omission or, worst-case, pills unaccounted for – which might prompt a safeguarding response if theft/diversion suspected).
  • Controlled Drugs: We reconcile the controlled drugs register with actual counts more frequently (could be daily in some settings, but in supported living maybe each visit or weekly if usage is low). This is critical for early detection of any diversion or error.
  • Ensure proper fridge storage for those needing it – check fridge temperatures or the general condition (we might not have a dedicated med fridge, but if they keep insulin in a home fridge, ensure the fridge seems functional and not freezing things).

A record of these audits is kept, noting date, who did it, and any discrepancies found and corrected. Patterns (like often finding paracetamol stocks off by a couple) might indicate staff forgetting to sign PRNs, etc., and then we’ll address the root cause.

• Competency Audits: While discussed in Training, periodically the manager might spot-audit staff competency by observing a med round unannounced or doing a quick Q&A during supervision (“show me how you’d fill out MAR if someone refused”). This monitors that training translates to ongoing practice.
• Incident Audits: We maintain a log of all medication incidents (errors, near misses). On a quarterly basis (or more often if needed), we analyze this log to identify any trends: For example, is there a particular time of day when errors occur (maybe evening shifts)? A particular medication that’s often involved (maybe a complex dosing schedule one)? A particular staff member making repeated errors (indicating more training needed or other support)? Trends might also highlight system issues like confusing MAR design or packaging. Based on analysis, we implement changes – e.g., if evening errors are due to staff fatigue or being rushed, maybe adjust shift patterns or ensure a second check at that time. We also share de-identified learning points with the team so everyone can improve (just culture approach).
• External Audits: We also welcome audits or reviews by external bodies when they occur: e.g., pharmacists may do medication audits especially if we’re part of any local authority quality programs, or CQC inspectors will effectively audit our med management during inspections. Any feedback from these is taken seriously, and we incorporate their recommendations into our practice.
• Audit Tools: We might use a standardized medication audit checklist (covering storage, documentation, adherence to policy, etc.) to ensure consistency in what we check each time. This can be a simple tick-list with room for notes and actions.

Auditing PRN Efficacy and Use:

• As part of reviews, we audit how often PRNs are used and whether they achieved the desired outcome. If a PRN for pain is used very frequently and often marked “not effective,” that’s flagged for medical review as mentioned earlier. Also, audit if PRNs that should be reviewed (like psychotropic PRNs for behavior) are indeed being reviewed and not just left on MAR indefinitely without oversight.

Audit of Records Communication:

• We ensure that when people transfer settings (e.g. go to hospital or respite), medication information is properly communicated by auditing a sample of recent transfers. Did we send a meds list? Did we receive one back? Any errors occurred during transitions? This helps tighten our processes around admissions/discharges, etc.

Governance and Reporting:

• Audit results are summarized and reported in governance meetings (like a quality assurance meeting or management review). For example, “This quarter, 2 medication errors (both missing signatures, no harm), storage audit compliance 95% (issues: one person had expired cream still present – removed now), MAR audit shows improvement in PRN documentation,” etc. This high-level overview helps management see the big picture and allocate resources (like if a lot of issues, maybe bring forward refresher training or do a targeted improvement project).
• We also include medication management performance in our periodic reports to any stakeholders (like if required by commissioners or as part of our service quality reports). It demonstrates our commitment to safe care.

Action Plans:

• Where audits find shortfalls, we create action plans with deadlines. E.g., “Audit found staff not consistently writing codes in MAR for refusals – Action: rebrief all staff at next team meeting, and include MAR coding in next supervision. Re-audit in one month.” Then we follow up to ensure the action had impact.

Resident/Service User Feedback:

• Indirectly, we “audit” how service users feel about their medication support. Through keyworker discussions or surveys, we might ask “Are you happy with how staff help you with your medication? Do you feel informed about what you’re taking? Any concerns?” This feedback can catch issues not evident in records – e.g., a person might say “Different staff give it differently and I get confused.” That’s something to fix (consistency, communication).
• Also, if someone complains about med errors or near misses, that will trigger an audit/investigation beyond routine.

Learning from Audits:

• Audit isn’t just fault-finding; it’s a learning tool. After completing an audit, we often share positive findings (“100% of MARs signed this month, great job!”) to reinforce good practice, as well as areas to improve (“Let’s all double-check expiries; audit found 3 items expired – now removed. Going forward, end-of-month check added to tasks.”).

Compliance with Policy:

• We also use audits to ensure staff are following this policy itself. For example, audit that everyone knows to follow consent/MCA – we might check a sample of cases where someone lacks capacity and see if documentation is in place for best interest and covert if applicable. Or audit training records to see all staff are up-to-date (which ties into Section 16). This meta-audit ensures our written policy is actually in action and remains fit for purpose.

Audit of Policy Review:

• Although more relevant to Section 21, as part of governance we audit that we review this policy at scheduled intervals and that any changes in law are incorporated. (E.g., “Checked that policy aligns with latest NICE NG67 update from 2024, and with LPS once in force.”) This might not be done by care staff but by management or an external quality consultant.

Through vigilant auditing and monitoring, we create a feedback loop for quality improvement. It helps us provide evidence to regulators that we don’t just set procedures, but we actively ensure they are working and being followed. Most importantly, it keeps service users safe by catching and correcting potential issues before they result in harm. Our auditing practices embody the mantra: Plan – Do – Check – Act in medication management.

18. Handling Errors and Incidents

Even with robust systems in place, medication errors or incidents can occur. How we respond to these situations is critical for ensuring the safety of our service users and for learning to prevent future mistakes. Our approach is in line with a “fair blame” culture – we encourage open reporting of errors without unreasonable punishment, focusing on resolving immediate risks and learning from the incident. This satisfies our duties under Regulation 12 (safe care) and Regulation 20 (Duty of Candour) to be transparent when things go wrong.

Types of Medication Incidents:
These include errors in prescribing (less likely within our service as we don’t prescribe, but we could spot an error on a GP script), dispensing errors by pharmacy (e.g., wrong medication supplied), administration errors (wrong dose, wrong time, wrong person, missed dose, etc.), documentation errors (MAR mistakes that could lead to risk), near-misses (caught just before reaching the person), or adverse drug reactions.

Immediate Actions When an Error is Discovered:

1. Ensure Safety of the Service User: This is top priority. Depending on the nature of the error:
   • If a dose was missed or significantly delayed: Evaluate the potential impact. For some meds, a late or skipped dose may have minimal effect; for others, it could be critical. If in doubt or if it’s a medication like insulin, epilepsy meds, heart meds, etc., consult a healthcare professional promptly (call GP or NHS 111). They may advise to give the dose as soon as remembered or to wait until next dose, etc. Monitor the person for any symptoms due to the missed dose (e.g., seizure activity, pain, etc.).
   • If an wrong medication or overdose was given: If it’s potentially harmful, contact emergency services or poison control immediately for advice. For example, if a double dose of blood pressure pills was given, monitor blood pressure and watch for dizziness; likely call GP for advice, potentially 999 if signs of overdose. If a wrong person took someone else’s pill, identify the pill and inform GP/hospital about what it was and the person’s health conditions to assess risk.
   • If a medication was given via wrong route (e.g., ear drops in eye), immediately rinse/clean area as appropriate and seek medical advice.
   • For adverse reactions or allergies: If someone shows signs of a serious allergic reaction (anaphylaxis: difficulty breathing, swelling, rash), call 999 immediately and prepare to administer any emergency measures if available (like an EpiPen if they have one). For milder suspected side effects, contact GP to report and get guidance.
   • In all cases, keep the person under closer observation after an error, even after advice, to catch any delayed effects. Document vital signs if relevant (pulse, BP, etc.) and the person’s subjective state (“feels fine” or “has mild nausea”).
2. Inform the Person and Provide Support: As per Duty of Candour, we explain to the service user (and their family if appropriate, especially if serious) what has happened, as soon as they are stable and it’s appropriate to do so. Example: “I’m sorry, I made a mistake and gave you another client’s tablet. I have spoken with the GP and this is what we are doing about it…” or “You missed your dose this morning because we overlooked it; we will monitor you and have informed the doctor.” We apologize sincerely and reassure them of the actions being taken to prevent harm. Many times, this honesty actually builds trust because we’re being transparent and caring. We also apologize to family/advocates as needed and assure them of the response.
3. Immediate Reporting: Staff must report the incident to their line manager or the Registered Manager immediately (as soon as the service user’s immediate needs are addressed). Even if the error seems minor and without consequence, it needs to be reported. If the manager is not on site, call them or the on-call supervisor. This enables oversight and assistance in managing the situation.
   • If medical attention was sought (GP/ambulance), also notify the manager of the outcome or instructions given.
4. Document the Incident: The staff involved (or who discovered it) should promptly and accurately document what occurred in an incident report form. This should include: date/time, who was involved, exactly what happened (e.g., “8pm dose of Drug A 50mg was not administered”), observed effects on the service user, actions taken (who was notified, any treatment given), and the signatures of staff reporting. Avoid judgmental language; stick to facts. If multiple staff have info, they may each add their notes or one comprehensive report can be compiled.
   • On the MAR chart, the dose in question should be circled or annotated with an error note (e.g., “error – see incident report”) so it’s clear for the record why there’s a discrepancy.
   • The person’s care notes for that day should also reflect the event and that it’s being managed.

Investigation and Follow-Up:

• The Registered Manager (or a designated investigating officer) will look into the root cause of the incident. They may interview the staff involved (in a supportive fact-finding way), review the MAR and any other evidence. They ask questions like: Was the policy followed? Were two checks done? Was staff rushed or interrupted? Is there a pattern (this person made similar mistakes before, or the system in that house might be confusing)? For example, if the error was giving medication to the wrong person in a shared house, maybe the medications were stored close together or packaging looked similar – a system issue to fix. Or if a dose was missed due to staff not turning up on time, that’s a scheduling issue.
• Based on the findings, the manager will decide on actions: this could include additional training for staff (indeed, per policy, any staff making an error will get refresher training and competency reassessment before administering again), changes in procedure (like introducing a double-sign check at night if errors happen in that shift), or disciplinary action if it was due to negligence or misconduct. Our emphasis is on learning, not blaming, but if a staff was willfully negligent (say, they knowingly didn’t give a med and falsified the record), that becomes a disciplinary matter.
• The outcome of investigation and actions taken are documented. We might complete an “incident investigation report” detailing cause and corrective measures.

Notification to External Bodies:

• We abide by CQC’s notification regulations. Notifiable incidents: If a medication error results in certain outcomes, we notify CQC under Regulation 18 of Registration Regs. Specifically, CQC must be told if the error led to:
  • The death of a service user (e.g., fatal overdose or lack of life-saving med).
  • A serious injury or harm (for instance, required hospital admission or caused permanent harm).
  • An incident that amounts to abuse or allegation of abuse – e.g., if the error was intentional or recklessly negligent, or frequent errors are considered neglect.
  • Involvement of the police – for example, if medication was stolen (theft) or a staff intentionally harmed via medication.
    When notifying CQC, we clearly state that a medication error occurred and was a known or possible cause of the harm. We use their notification forms per guidance.
• Safeguarding Authorities: If the error meets local safeguarding criteria (like significant harm or multiple minor harms indicating neglect), we raise a safeguarding alert to the local Safeguarding Adults team. For instance, giving someone else’s morphine could be a safeguarding issue even if accidental, because of the potential severity. We are transparent with safeguarding investigations and implement any recommendations.
• GP/Prescriber: We inform the person’s GP about the error (unless it was so minor and had no effect, but as a courtesy often still do, especially if it might affect treatment decisions). This keeps them in the loop and also they might want to do a check-up or note it in their records.
• Controlled Drugs Accountable Officer (CDAO): If the incident involved controlled drugs (especially loss, theft, or serious harm), we notify the NHS CDAO as required. Usually, our policy is any CD incident gets reported through the required channels (via the CD reporting tool or email to CDAO).
• Family/Advocate: With consent and as appropriate, we inform the next-of-kin or advocate after an incident, particularly if it’s moderate or above harm or if we needed to get emergency help. Even if no harm, if the individual lacks capacity, their family or advocate should be informed under duty of candour. We do this sensitively and assure them of actions taken.

Post-Incident Support:

• We ensure the service user is monitored until any risk from the error has passed. If they went to A&E or hospital, we liaise to ensure when they return we have updated info (like any new treatment because of the error).
• We reassure the service user (and family) and check if they have any ongoing concerns or needs (maybe a bit of anxiety about medication now – we might spend more time explaining or double-checking with them present to rebuild trust).
• We also consider the well-being of staff involved. Committing a med error can be very distressing for a conscientious staff. We have a debrief with them – not to scold, but to discuss what happened, how they feel, and how to prevent recurrence. We encourage them to learn but also not to be overly harsh on themselves if it was an honest mistake, so long as they reported it properly. That being said, if it was due to a clear breach of procedure, we address that firmly but fairly.

Learning and Prevention:

• Every incident is an opportunity to improve our system. As described in Auditing (section 17), we log incidents and periodically analyze them for trends. If we see, say, multiple staff confused by similar packaging, we’ll implement a change (like better labeling or separating storage). If training gaps are identified, we organize refreshers.
• We share anonymized lessons at staff meetings: “We had an incident where X happened. Everyone, please remember to do Y and Z to avoid that.” The idea is collective learning rather than individual blame.
• We update our policy or procedures if needed. For example, if an error revealed a flaw in the policy, we fix it.

Near Misses:

• A near miss (e.g., staff nearly gave wrong tablet but realized at last second) is treated almost like a real error in terms of reporting and analyzing (minus the emergency responses since no harm occurred). We encourage staff to report near misses too, because they highlight weaknesses. We respond by figuring out why it almost happened and fix that – maybe a lookalike medication was stored alongside another, etc. We praise staff for reporting near misses as it shows alertness and honesty.

Duty of Candour Compliance:

• In any case of significant harm or potential harm, we follow Duty of Candour procedures fully: which include informing relevant persons, providing all facts, apologizing, and keeping a written record of that communication. We also provide updates and investigation findings to the person/family in writing if it was a notifiable safety incident (generally moderate/severe harm incidents).
• We keep records of those communications (letters, etc.) in our incident file to demonstrate to CQC that we carried out duty of candour steps.

By handling errors and incidents in this comprehensive manner, we aim to minimize any harm to service users and use the experience to strengthen our medication management. Our goal is a transparent, responsive approach where service users and families know we’ll tell them the truth and do right by them if something goes wrong. This open culture ultimately contributes to safer care because everyone is focused on improvement rather than hiding mistakes.

19. Disposal of Medicines

Proper disposal of medications is important to prevent environmental contamination, misuse of leftover drugs, and to keep everyone safe (particularly in a home environment where others could accidentally ingest discarded medicines). Our service follows safe procedures for disposing of any medicines that are no longer needed or have expired.

When Medicines Need Disposal:

• Discontinued Medication: If a doctor stops a medication or changes the dose, any remaining old stock of that medication that is no longer needed should be removed from current use. For example, if the GP says “stop Drug X” or “we’re switching from 10mg tablets to 5mg tablets”, the old 10mg tablets must be taken out of the person’s medication supply to avoid accidental use.
• Expired Medication: All medicines have an expiry date. Some also have a shorter use-by once opened (like eye drops often expire 4 weeks after opening). Staff check expiry dates during routine audits (monthly) and whenever administering (especially PRN that sits around longer). If the date is past, we mark those for disposal.
• Medications of a Deceased or Discharged Service User: If someone leaves the service or passes away, their medications (which are legally their property or their estate’s property) should be disposed of safely – usually by returning to a pharmacy – unless a coroner or doctor advises holding them temporarily in case of investigation.
• Partially Used or Unused Medicines: Often at the end of a monthly cycle, there might be leftover tablets (maybe dose was reduced mid-cycle, or person skipped some PRN, etc.). We don’t hoard these indefinitely. If they’re still currently prescribed and not expired, they can be carried over to next cycle (less waste) if packaging is intact and it’s safe to do so. But if in doubt or if excess builds up, we arrange disposal of the extra to keep only reasonable stock.
• Sharps: Though rare in personal care context, if any injections or pen needles are used by the person (like insulin pens), used sharps must go into a proper sharps container for disposal, not general waste. Once the sharps bin is full or no longer needed, it is sealed and returned via pharmacy or local council clinical waste services.
• Sharps Management: Where medicines support involves needles, lancets, insulin pen needles or other sharps, approved sharps containers will be used.

Staff will:

• never place used sharps in household waste;
• never recap, bend or manually dismantle needles unless specifically required by the device manufacturer’s instructions and supported by training;
• dispose of sharps immediately after use into the appropriate container;
• ensure sharps containers are kept upright, secure and inaccessible to unauthorised persons;
• not overfill sharps containers;
• arrange collection or return through the appropriate local clinical-waste or pharmacy arrangements; and
• report needlestick injuries immediately and follow the organisation’s exposure-management procedure.
• Staff undertaking tasks involving sharps must have received task-specific training and competency assessment.

How We Dispose of Medicines:

• We do not throw medicines in the household trash or flush them down toilets/sinks, as this can be hazardous. Instead, we use pharmacy take-back services.
• Return to Pharmacy: Our primary method is to return unwanted or expired medications to a local community pharmacy for safe disposal (they have systems to incinerate or process as hazardous waste). We have arrangements with the pharmacies that supply our service users. When preparing to return medicines:
  • We get the service user’s (or their representative’s) consent if needed, since technically the medicines belong to them. Usually they’re fine with disposing what’s not needed, but we still involve them: “These pills are old or stopped, so we’ll take them to the pharmacy to safely destroy, okay?”
  • A staff member will collect the meds to be disposed of, ideally list them out and count quantities. For controlled drugs, this is especially important (and often needs a pharmacist witness for destruction, but generally pharmacy handles that). We put the items in a bag and bring it to the pharmacy.
  • At the pharmacy, we ask for a receipt or signature confirming they received X, Y, Z for destruction. If they won’t sign per se, the staff member notes the date, pharmacy name, and who they handed it to. This receipt or note is kept in our records (perhaps attached to the medication disposal log or the person’s file). This provides an audit trail that we followed through.
• Medication Disposal Log: We maintain a log sheet (maybe in each home’s folder or centrally) noting all disposals: Date, Service User, Medication name/strength, quantity, reason (expired/stopped), and how disposed (e.g., “Returned to ABC Pharmacy, signed by [pharmacist name]” or “collected by council clinical waste service on [date]” etc.). Both the staff and (if applicable) pharmacist sign off. This aligns with guidance that returns should be documented.
• Controlled Drugs Specifics: For controlled drugs, we handle similarly but with extra caution:
  • We inform the pharmacist that it’s a controlled drug so they can follow their legal procedure (they may require that the destruction be witnessed by an authorized person before signing it off).
  • In our CD register, we record the removal: e.g., “5 tablets of morphine 10mg returned to pharmacy for destruction on [date] – balance now 0” and get a signature from the pharmacist or 2 staff witnesses if pharmacy doesn’t sign. This closes the loop in the register.
  • If a controlled drug cannot be immediately taken to pharmacy (say, a dose was refused and now can’t be reused but you’re mid-visit), staff can temporarily store it securely (e.g., seal it and keep in locked cupboard) but as soon as possible take it to pharmacy. Do not leave it indefinitely.
  • We never destroy controlled drugs ourselves (like by flushing); except maybe in an emergency scenario to render it unusable if absolutely needed, but normally let the pharmacy or CDAO-approved method do it.
• Disposal in the Home: There could be cases where a med needs discarding at home (like a used patch or a dropped pill). For a used transdermal patch, we fold it sticky sides together and either put it in a sharps bin (since it has drug residue) or into a bag to return to pharmacy. A dropped pill that can’t be used – we pick it up and also dispose via pharmacy (we might put it in a small container until then). We avoid washing it down sink or bin because a pet or child could find it, or it could leach. We ensure these small items aren’t left lying around.
• Household Clinical Waste Collection: In some cases, especially with multiple service users or home healthcare tasks, the local council can arrange a clinical waste collection (for sharps bins or large quantities). We use this as needed for items like used dressings with medicated cream or soiled patches. But for pure medication disposal, pharmacy return is simpler.

Service User Involvement:

• If a person likes to be involved in every aspect, we might have them accompany us to pharmacy to dispose or at least inform them as we do it: “We’re returning these old tablets you don’t need. The pharmacist will destroy them safely.” Most appreciate the diligence. Some might not want “waste” – if someone hoards or is reluctant to let meds go (“maybe I’ll need it later”), we gently explain the importance (out-of-date meds might not work or could be unsafe; plus the prescriber wants you only on current meds). If needed, involve their GP to reinforce that message.
• If a person has capacity and absolutely insists on keeping a discontinued med, that’s tricky: we’d try to persuade otherwise because it’s a risk. If they still insist, we document their decision (and it’s in their home after all). But perhaps get written confirmation from GP to give to them about dangers. In some cases, might consider it a risk factor in care plan (like monitor that they don’t take it; maybe lock it away). Usually though, people agree when explained.

Environmental and Safety Compliance:

• By returning to pharmacy, we comply with regulations on hazardous waste disposal (pharmacies have systems as part of NHS). Flushing meds can harm water supply; trash can lead to accidental ingestion by animals or people. We consciously avoid that.
• We also comply with Controlled Waste regulations for any med waste (like patches or sharps classified as clinical waste).

Documentation after Disposal:

• After disposing, we update the service user’s medication list and MAR: remove the item if no longer active, so it doesn’t accidentally get given.
• We also update the care plan if needed (like noting “Medication X stopped and disposed of on [date]”). This clarity ensures anyone reviewing knows it’s no longer in use.

Audit of Disposal:

• As part of our medication audits, we might check that any medicines in the person’s possession are still current. If we find an old med, we ask why wasn’t it disposed and then act. We keep disposal records to show inspectors if asked how we handle med waste; CQC may ask “what do you do with unwanted meds?” – we can demonstrate our procedure and records of returns.

In conclusion, our disposal practices are safe, legal, and respect the environment. We ensure that once a medication has served its purpose (or can no longer be used), it is removed promptly and disposed of responsibly. This protects service users (no outdated or excess meds lying around to confuse or tempt misuse) and upholds our duty of care beyond administration itself, extending through the full lifecycle of medicines in our service.

20. Confidentiality and Data Security

Handling medication information involves dealing with personal and sensitive health data. We are committed to maintaining confidentiality and protecting this data in compliance with the Data Protection Act 2018, UK GDPR, and Caldicott principles. Additionally, respecting privacy is part of the CQC’s Fundamental Standards (Regulation 10: Dignity and respect includes confidentiality of personal info). This section outlines how we ensure confidentiality and security of medication records and information.

Confidentiality Principles:

• Need-to-Know Basis: Information about a service user’s medications and health is only shared with those who need it to provide care or for safety reasons. Care staff working with the individual obviously need to know their medication details. Other service users or unauthorised persons (even other staff not involved in that person’s care) are not privy to someone’s medication records.
• Consent to Share: We obtain consent from service users regarding sharing their medication information with family members or others. For example, many people are fine with us discussing their meds with their next-of-kin, especially if they help with care, but we confirm this in their care plan preferences. If someone says “I don’t want my daughter to know about my antidepressant,” we respect that and keep it confidential, unless a legal requirement overrides (like safeguarding). For individuals who lack capacity, we share info with their lawful representatives (e.g., health-and-welfare LPA) or in best interests.
• Private Discussions: When discussing medications or doing medication-related tasks, we do so in a way that preserves privacy. In supported living, this means if in a shared environment, we try to speak quietly or in a private area about someone’s meds rather than in front of housemates. For example, don’t announce “Here’s your HIV medication” in earshot of others – keep such information discreet. If family or visitors are present and the person doesn’t want them to know certain details, we might administer more subtly or ask the visitor to step out briefly, per the person’s wishes.

Secure Storage of Records:

• Paper Records (MAR, care plans): In an individual’s home, paper records like the MAR chart, care plan, risk assessments etc., should be kept in a secure manner. Ideally, there is a designated folder or file stored in a location not easily accessible by visitors. Some people have a lockable cabinet for their care files (but it must be accessible to staff when needed). If not locked, it should at least be closed and kept in a private room. Staff ensure, after writing in MAR or notes, to put them back in that place. We advise service users not to leave their MAR chart open on a coffee table, for instance, as it contains personal health info.
• Electronic Records: If we use an electronic MAR or maintain digital copies of care plans, these are protected by secure systems (passwords, encryption). Staff access them via authorised devices. Our policy is that staff do not save personal data on their own unsecured devices. They use company-provided devices or secure portals. For example, an eMAR app might be used on a tablet with login credentials. We ensure devices are set to auto-lock and have encryption.
• Emails/Communication: When sending medication information via email (e.g., to GP or when coordinating with another agency), we use secure email (NHSmail or encrypted email) if it contains identifiable details. We avoid including full details in standard email without protection. Fax is largely obsolete but if used in rare cases, ensure a safe line and cover sheet stating confidential.
• Telephone: If discussing medication info over phone (like calling GP or pharmacy), we first confirm we’re speaking to the correct professional. We also make sure not to do it on speakerphone with bystanders who shouldn’t hear.

Confidentiality in Practice:

• Staff are trained and regularly reminded not to talk about a service user’s medication or health issues with anyone outside the care context. For instance, no chatting about “Oh, Mrs. Y takes strong painkillers” to your friends or to other clients. That’s a breach.
• Even within the team, we only share relevant info. A staff member who is not on that person’s care team shouldn’t peruse their MAR out of curiosity. Our documentation is usually kept person-specific to avoid unnecessary exposure (i.e., we don’t have one binder with all service users MARs sitting around; each person has their section or separate record).

Accessible Information and Privacy:

• We comply with the Accessible Information Standard, meaning we provide information about medications to the person in a way they can understand (easy-read, large print, etc.), but we do so while still maintaining privacy. For example, if someone needs pictograms to identify their meds, we help with that privately.
• Also, if a person wants to look at their own records (they have a right to), we facilitate that. They own their MAR information and can see it on request.

Data Retention and Disposal:

• We keep medication administration records and related documents for the required retention period (usually 8 years for adult social care records after discharge/death, or per organisational policy). During retention, they are stored securely (archived in locked cabinets or secure server).
• When disposing of old records beyond retention, we shred or incinerate paper documents and securely delete electronic files. Old MAR charts or printed prescriptions are shredded – they contain names, medications, etc. We would never just throw them in general waste.

Privacy during Medication Administration:

• We try to ensure the person’s privacy when giving meds. If they need assistance with, say, an injection in a private area or to apply a cream in a personal area, we do that in a private room with door closed, maintaining dignity.
• We also cover or remove any clothing discreetly, only as needed for that task.
• This might be more dignity than confidentiality, but it overlaps (keeping their health interventions private from others).

Protecting Digital Systems:

• We follow IT security best practices: strong passwords, not sharing login credentials, logging out of eMAR systems after use, and not accessing records on public Wi-Fi without VPN or other protections. If staff use tablets, those tablets are managed by the organization with remote wipe capability if lost.
• If any data breach were to occur (like lost MAR sheet or unauthorised access), we’d follow our data breach protocol (report to management, possibly ICO if serious, inform the individuals concerned, etc.).

GDPR Compliance:

• Our handling of medication data falls under health data (special category). We process it under lawful bases (usually explicit consent or provision of care/medical purposes under GDPR Schedule 1 conditions). We ensure service users know in our privacy notice that we keep records of their medications and share with GPs, etc., for their care.
• Staff sign confidentiality agreements as part of employment, acknowledging that they understand their duties under GDPR and confidentiality policies.

Conversations and phone calls:

• When staff speak about medications (for instance, to a GP or in handing over to another staff), they do so in a private setting as much as possible. E.g., don’t discuss a person’s med loudly in a public hallway or where other clients are around.
• If we need to call a family about a med issue, verify identity before divulging details (“Hello, is this [daughter’s name]? I’m [staff] from [service]. Just confirming I have the right person to discuss [client’s] care.”).

Medication Delivery Confidentiality:

• If pharmacy delivers meds, they usually come in a bag with label. We accept it directly – we don’t let it be left with a neighbor or in open where others might see the labels. If a person picks up their own meds, we encourage them to not show or share info with others if they want privacy (we educate them that it’s personal info).

Privacy vs Safety:

• There are rare occasions we might need to breach confidentiality for safety (e.g., if someone is overdosing intentionally, we’d share info with emergency responders about what they took, regardless of any prior wish for privacy – because life is at risk; or safeguarding scenarios). Such breaches are done under proper justification and usually with management consultation. We then document why that was necessary (legal requirements can override confidentiality in certain circumstances).

Confidential Waste:

• Any documents containing medication info that are to be discarded (like an old fax from GP, or an extra MAR print that wasn’t used) are put into “confidential waste” bins or shredded. Staff are instructed never to toss anything with names/meds into regular trash. Even pill package labels with names get shredded if we remove them.

By following these confidentiality and data security practices, we aim to maintain trust with our service users. They should feel confident that their personal health details and medication regimes are not being improperly disclosed. This approach aligns with professional ethics and legal mandates and contributes to individuals feeling respected and safe in our care.

21. Policy Review and Governance

To keep this Medication Management Policy effective and up-to-date, we engage in regular reviews and oversight as part of our governance processes. The care sector and medication practices are subject to evolving laws, guidance, and feedback from regulatory bodies (like CQC), so our policy must evolve accordingly. Additionally, through our own audits and incident learnings, we may identify needed changes. This section describes how we review, update, and govern adherence to the policy.

Scheduled Reviews:

• This policy will be formally reviewed on a yearly basis at minimum. The next scheduled review date is recorded on the policy document (internally, even if not printed on external version). For example, if last reviewed January 2025, then by January 2026 a review should be completed.
• Policy Owner: The Registered Manager (or designated Quality Manager in the organization) is responsible for initiating and coordinating the review. They will ensure all sections are examined for continued relevance and accuracy.
• During a review, we consider:
  • Changes in legislation or regulations since the last update (e.g., if the Health and Social Care Act regs get amended, or when Liberty Protection Safeguards replace DoLS, etc.). We incorporate any new legal requirements. For example, if a new Reg 19A came out affecting medication, we’d add it. Or if CQC issues new guidance or expectations (like an updated CQC inspection framework or NICE guideline updates), we integrate those references.
  • Changes in best practice: e.g., if NICE publishes a new guideline or update to NG67, or if professional bodies issue guidelines on medication in community, we reflect that.
  • Internal feedback: input from staff (maybe something in the policy is unclear or impractical and needs tweaking), from service users (perhaps requesting easier format or clarifications), or from incidents (if we had a trend of errors that suggests the policy could emphasize something more).
  • CQC Feedback or Inspection reports: If CQC in an inspection or PIR (provider information return) feedback highlighted any gap in our medication policy or terminology (like saying “you should mention ancillary to personal care” which we have), we ensure those points are covered explicitly. Since the prompt mentions “guidance and terminology highlighted in CQC feedback,” presumably we incorporate that, and on review we’d double-check that those remain addressed.
• Involvement in Reviews: We involve relevant stakeholders in the review. That can include:
  • Senior care staff or a medication lead (they can provide practical insight).
  • The organization’s pharmacist or nursing advisor if we have one, to lend clinical accuracy.
  • Possibly service user representatives – maybe not in fine detail, but we might ask if they feel the procedures are working for them.
  • We also cross-check against any audits or quality improvement plans we have internally (Section 17’s audits might have an action “update policy to clarify X”).

Out-of-Schedule Updates:

• If a significant change occurs before the annual review (e.g., a new legal requirement comes into force, or a serious incident reveals a major policy gap), we will update the policy immediately rather than waiting. For example, if the law changes next month requiring a specific documentation for covert meds, we’d update Section 11 accordingly and re-issue the policy.
• Similarly, if CQC or commissioners give immediate feedback (like “your policy should mention STOMP for learning disabilities”), we incorporate that promptly.

Version Control and Approval:

• Each iteration of the policy is version-controlled internally. While the user doesn’t want a version control footer, we will maintain a version history in our files. E.g., Version 1 Jan 2025, Version 2 Jan 2026, etc., with summary of changes. This is for governance record.
• After a review/update, the revised policy is approved by the Registered Manager and if applicable by higher management or the board of the organization (depending on our governance structure). The approval is documented (like sign-off sheet).

Communication of Changes:

• Once reviewed and approved, any changes in the policy are communicated to all care staff. We might do this via a memo, an email summary of key changes, and/or a short briefing session. For example, “Policy updated: new procedure for documenting PRN outcomes, please read Section 10 again.” We may ask staff to sign a form or electronically acknowledge they have read the new version.
• We also update any training materials to reflect policy changes, so future training is consistent.

Accessibility of Policy:

• The current version of this policy is readily accessible to staff (stored in policy manuals on-site or on our internal care management system). We encourage staff to refer to it whenever in doubt and as part of their induction refresh reading. Frontline staff often won’t memorize a 20-page policy, but they should know the key points and where to find details.
• A service user or representative can request to see our medication policy as well – we would provide it (perhaps in a simpler summary form if needed) to show our commitment to safe practice. Non-confidential policies like this are often shared.

Governance Oversight:

• Medication management is a standing agenda item in governance meetings (like quality meetings, clinical governance if applicable). The Registered Manager provides updates: number of incidents, audit results, training status, and whether the policy is being followed or needs changes.
• If any compliance issues are identified (e.g., a staff or site consistently not following the policy), management addresses it through further training or disciplinary processes as needed. The policy is only as good as its implementation; governance monitors that.
• Conversely, if the policy is found to have positive outcomes (like reduction in errors), that too is noted and celebrated as it means our processes are effective.

Integration with Other Policies:

• This Medication Management Policy may link with other organizational policies (e.g., Record Keeping Policy, MCA/Consent Policy, Safeguarding Policy, Infection Control in Medicines tasks, etc.). As part of review, we ensure consistency across them. For instance, our Consent Policy should echo what’s here about consent for medication; Safeguarding Policy should mention med errors can be safeguarding in some cases, etc. Governance ensures these cross-links are coherent.

Audit of Policy Adherence:

• As mentioned in Auditing (section 17), part of our monitoring is seeing if practice aligns with policy. If we find deviations, we ask is the policy unrealistic or did staff need more support? Then either we adjust practice or policy accordingly.
• For example, if policy says two staff must always sign for CDs but we only ever have one staff present, that’s a mismatch – either we change policy to allow one with verification or we change staffing. Such issues would be sorted out at review.

CQC Compliance and Registration:

• We ensure this policy supports compliance with the relevant Regulated Activities (Personal Care) under our registration. If we were to register for additional activities (like Treatment of Disease etc.), we’d adapt accordingly. Right now, it’s framed for Personal Care in Supported Living and references that context (ancillary to personal care) which addresses what CQC expects.
• Also, we ensure any CQC (Registration) Regs around notifications (Reg 18) and so forth are integrated (as we have in Section 18). If the Regs update, we update those references too.

Organisational Governance Support:

• If we have a central compliance team or access to external consultants (like policies from a provider association or legal advisors), we might have them review our policy for thoroughness and compliance. This is especially done if there are big changes in law to ensure we interpret correctly.

In summary, our policy review and governance process ensures that this document is not static. It evolves with time and guides actual practice. By regularly reviewing and governing its implementation, we maintain a living policy that truly supports safe, effective medication management in our supported living service, rather than a file gathering dust.

By adhering to this Medication Management Policy, {{org_field_name}} ensures a consistent, safe approach to supporting service users with their medicines. All staff must follow the procedures outlined. Any questions or uncertainties about medication tasks should be raised with a supervisor or the Registered Manager ({{org_field_registered_manager_first_name}}) immediately. Through teamwork, continuous training, and adherence to this policy, we strive to uphold the highest standards of care in medication management, in line with CQC requirements and, most importantly, in the best interests of those we support.

---

Responsible Person: {{org_field_registered_manager_first_name}} {{org_field_registered_manager_last_name}}
Reviewed on: {{last_update_date}}
Next Review Date: {{next_review_date}}
Copyright © {{current_year}} – {{org_field_name}}. All rights reserved.